| Gene Symbol | Pearson Correlation Coefficient |
|---|---|
| ATP6V1A | 0.975 |
| ATP6V1C1 | 0.974 |
| TRIM37 | 0.973 |
| RNMT | 0.972 |
| KIF3A | 0.972 |
| UBE2K | 0.972 |
| SYNJ1 | 0.971 |
| ZYG11B | 0.971 |
| WDR47 | 0.97 |
| MTMR9 | 0.969 |
| Gene Symbol | Pearson Correlation Coefficient |
|---|---|
| OR4F5 | -0.532 |
| CSAG1 | -0.489 |
| OR4F29 | -0.489 |
| HEY2 | -0.464 |
| RHOD | -0.447 |
| RAB13 | -0.443 |
| MYL3 | -0.44 |
| ROM1 | -0.426 |
| COPZ2 | -0.426 |
| CNN2 | -0.425 |
| ID | Drug Name | Drug Type | CAS Num | Status | Role |
|---|---|---|---|---|---|
| DB01356 | Lithium | Small Molecule | 7439-93-2 | Approved | Target |
| DB01772 | 3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione | Small Molecule | Experimental | Target | |
| DB01793 | SB-409513 | Small Molecule | Experimental | Target | |
| DB01950 | N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea | Small Molecule | Experimental | Target | |
| DB02010 | Staurosporine | Small Molecule | 62996-74-1 | Experimental | Target |
| DB02052 | Indirubin-3'-Monoxime | Small Molecule | Experimental | Target | |
| DB03444 | (3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime | Small Molecule | Experimental | Target | |
| DB04014 | Alsterpaullone | Small Molecule | Experimental | Target | |
| DB04395 | Phosphoaminophosphonic Acid-Adenylate Ester | Small Molecule | Experimental | Target | |
| DB07014 | 2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole | Small Molecule | Experimental | Target | |
| DB07058 | 5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione | Small Molecule | Experimental | Target | |
| DB07149 | (7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one | Small Molecule | Experimental | Target | |
| DB07584 | N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | Small Molecule | Experimental | Target | |
| DB07585 | 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine | Small Molecule | Experimental | Target | |
| DB07676 | 3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one | Small Molecule | Experimental | Target | |
| DB07812 | N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide | Small Molecule | Experimental | Target | |
| DB07859 | 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE | Small Molecule | Experimental | Target | |
| DB07947 | ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE | Small Molecule | Experimental | Target | |
| DB08073 | (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE | Small Molecule | Experimental | Target | |
| DB12129 | Tideglusib | Small Molecule | 865854-05-3 | Investigational|Withdrawn | Target |
| ID | Drug Name | Action | PubMed |
|---|---|---|---|
| C025603 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | "1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein]" | 25433145 |
| C048792 | 1,2-diacetylbenzene | "1,2-diacetylbenzene affects the phosphorylation of and results in increased activity of GSK3B protein" | 28734998 |
| C048792 | 1,2-diacetylbenzene | "2-thio(3-iodobenzyl)-5-(1-pyridyl)-(1,3,4)oxadiazole inhibits the reaction [1,2-diacetylbenzene affects the phosphorylation of and results in increased activity of GSK3B protein]" | 28734998 |
| C048792 | 1,2-diacetylbenzene | "1,2-diacetylbenzene affects the phosphorylation of and results in increased activity of GSK3B protein" | 28734998 |
| C517232 | 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane | "1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane results in decreased expression of GSK3B mRNA" | 23958786 |
| C532657 | 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one analog inhibits the reaction [Asbestos, Serpentine results in increased phosphorylation of GSK3B protein]" | 26685284 |
| C532657 | 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein]]" | 28245986 |
| C532657 | 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein]]" | 28245986 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of GSK3B protein" | 21705713 |
| C095284 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one | "1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [resveratrol results in increased activity of GSK3B protein]" | 19135050 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in decreased phosphorylation of GSK3B protein" | 19584227|2280195 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "[ERBB2 gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in decreased phosphorylation of GSK3B protein" | 20453058 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "[OGT mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in decreased phosphorylation of GSK3B protein" | 23029544 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "[PTEN gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in decreased phosphorylation of GSK3B protein" | 20453058 |
| C477694 | 2,2',4,4',5-brominated diphenyl ether | "2,2',4,4',5-brominated diphenyl ether results in decreased phosphorylation of and results in increased activity of GSK3B protein" | 24218147 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein] | 20696143 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein] | 20696143 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride results in decreased phosphorylation of GSK3B protein] | 20937724 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride results in increased activity of GSK3B protein] | 20937724 |
| C505456 | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in decreased phosphorylation of GSK3B protein] | 18806606 |
| C505456 | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in increased phosphorylation of GSK3B protein] | 16716347 |
| C505456 | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one promotes the reaction [Isoproterenol results in increased phosphorylation of GSK3B protein] | 15951400 |
| C505456 | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one results in increased phosphorylation of GSK3B protein | 15951400 |
| C093026 | 2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside | "2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased phosphorylation of GSK3B protein]" | 23911879 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in decreased phosphorylation of GSK3B protein" | 20394812 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Neomycin results in increased phosphorylation of GSK3B protein] | 15800129 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [DEFA1 protein results in increased phosphorylation of GSK3B protein] | 19814765 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [DEFA2 protein results in increased phosphorylation of GSK3B protein] | 19814765 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IGF1 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of GSK3B protein]] | 20064577 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Polychlorinated Biphenyls analog results in decreased expression of GSK3B protein] | 24361488 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein] | 20696143 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of GSK3B protein] | 14750165 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Zinc results in increased phosphorylation of GSK3B protein] | 17513037 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein] | 20696143 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in increased activity of GSK3B protein | 15942663|1966122 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein | 21821001|2204644 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein] which results in decreased susceptibility to Bleomycin | 19429264 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased activity of GSK3B protein | 15753396 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | GSK3B mutant form inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] | 21821001 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | GSK3B results in decreased susceptibility to 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 21821001 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | Tamoxifen promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein] | 22046442 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EPO protein results in increased phosphorylation of and results in increased activity of GSK3B protein] | 17928571 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased phosphorylation of GSK3B protein] | 15845746 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [Okadaic Acid affects the phosphorylation of GSK3B protein]] | 27050422 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein] | 20542495 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | "2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Toluene 2,4-Diisocyanate results in increased phosphorylation of GSK3B protein]" | 26089345 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein | 16179367 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | GSK3B mRNA affects the susceptibility to 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 21832246 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of GSK3B protein] | 20064577 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [5-aminoisoquinolinone inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of GSK3B protein]] | 23352507 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ecdysterone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of and results in decreased activity of GSK3B protein]] | 26048653 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EPO results in increased phosphorylation of GSK3B protein] | 17952604 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [gypenoside analog results in increased phosphorylation of GSK3B protein] | 24726523 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phytoestrogens results in increased phosphorylation of GSK3B protein] | 24726523 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of GSK3B protein] | 24231000 |
| C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of GSK3B mRNA" | 21346803 |
| C076996 | 27-hydroxycholesterol | 27-hydroxycholesterol results in decreased expression of GSK3B protein | 20157255 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "[chlorophyllin affects the reaction [2-amino-3-methylimidazo(4,5-f)quinoline results in increased mutagenesis of CTNNB1 gene]] inhibits the reaction [GSK3B protein results in increased phosphorylation of and results in increased ubiquitination of CTNNB1 protein]" | 12628520 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [IGF1 protein results in increased phosphorylation of GSK3B protein] | 20053781 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein] | 20053781 |
| C029955 | 2-nitrotoluene | 2-nitrotoluene affects the expression of GSK3B mRNA | 16460773 |
| C529548 | 2-thio(3-iodobenzyl)-5-(1-pyridyl)-(1,3,4)oxadiazole | "2-thio(3-iodobenzyl)-5-(1-pyridyl)-(1,3,4)oxadiazole inhibits the reaction [1,2-diacetylbenzene affects the phosphorylation of and results in increased activity of GSK3B protein]" | 28734998 |
| C529548 | 2-thio(3-iodobenzyl)-5-(1-pyridyl)-(1,3,4)oxadiazole | "2-thio(3-iodobenzyl)-5-(1-pyridyl)-(1,3,4)oxadiazole results in decreased activity of GSK3B protein" | 28734998 |
| C529548 | 2-thio(3-iodobenzyl)-5-(1-pyridyl)-(1,3,4)oxadiazole | "2-thio(3-iodobenzyl)-5-(1-pyridyl)-(1,3,4)oxadiazole results in decreased activity of GSK3B protein" | 23085120 |
| C417520 | 3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione | "3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione results in decreased activity of GSK3B protein" | 19486905 |
| C417520 | 3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione | "[3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione results in decreased activity of GSK3B protein] inhibits the reaction [Sirolimus results in decreased expression of CCND1 protein]" | 15753396 |
| C417520 | 3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione | "3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione results in decreased activity of GSK3B protein" | 19159680 |
| C417520 | 3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione | "[3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein" | 19159680 |
| C417520 | 3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione | "3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione results in decreased activity of GSK3B protein" | 15475000|1594266 |
| C016392 | 3,3'-diindolylmethane | "3,3'-diindolylmethane results in decreased phosphorylation of GSK3B protein" | 22290291 |
| C497286 | 3,4',5-trimethoxystilbene | "3,4',5-trimethoxystilbene results in decreased phosphorylation of and results in increased expression of GSK3B protein" | 23921149 |
| C546412 | 3-((4-chlorobenzyl)oxy)-N-((1S)-1-phenylethyl)-2-thiophenecarboxamide | 3-((4-chlorobenzyl)oxy)-N-((1S)-1-phenylethyl)-2-thiophenecarboxamide results in increased phosphorylation of GSK3B protein | 19694723 |
| C035055 | 3,4-dihydroxyphenyllactic acid | "3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of GSK3B protein]" | 29128606 |
| C562244 | 3-(5-(4-(2-hydroxy-2-methylpropionyl)piperazin-1-yl)-2-trifluoromethylphenyl)-4-(1H-indol-3-yl)pyrrole-2,5-dione | "3-(5-(4-(2-hydroxy-2-methylpropionyl)piperazin-1-yl)-2-trifluoromethylphenyl)-4-(1H-indol-3-yl)pyrrole-2,5-dione results in decreased activity of GSK3B protein" | 21155605 |
| C530773 | 3,5-diethoxycarbonyl-1,4-dihydrocollidine | "3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased phosphorylation of and results in decreased activity of GSK3B protein" | 20512997 |
| C008745 | 4,4'-bisphenol F | "4,4'-bisphenol F results in decreased expression of GSK3B mRNA" | 26186136 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSK3B mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSK3B mRNA" | 27188386 |
| C555021 | 4-acetylantroquinonol B | 4-acetylantroquinonol B results in decreased phosphorylation of GSK3B protein | 28408137 |
| C552996 | 4-aminoethylamino-emodin | 4-aminoethylamino-emodin binds to and results in decreased activity of GSK3B protein | 19228266 |
| C494356 | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione results in decreased activity of GSK3B protein" | 24824809 |
| C494356 | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [Kainic Acid results in decreased phosphorylation of GSK3B protein]" | 25453207 |
| C494356 | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione promotes the reaction [Valproic Acid inhibits the reaction [Kainic Acid results in decreased phosphorylation of GSK3B protein]]" | 25453207 |
| C494356 | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione results in decreased activity of GSK3B protein" | 22785175 |
| C494356 | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione results in decreased activity of GSK3B protein" | 15950778|2308512 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of GSK3B mRNA | 12419474 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased phosphorylation of GSK3B protein | 24825450 |
| C406734 | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased phosphorylation of GSK3B protein | 21442130 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of GSK3B protein | 12511591 |
| C012606 | 4-vinyl-1-cyclohexene dioxide | 4-vinyl-1-cyclohexene dioxide affects the expression of GSK3B mRNA | 20829426 |
| C060298 | 5,7-dimethoxyflavone | "5,7-dimethoxyflavone promotes the reaction [Diethylnitrosamine results in increased phosphorylation of GSK3B protein]" | 21554863 |
| C411425 | 5-aminoisoquinolinone | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [5-aminoisoquinolinone inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of GSK3B protein]] | 23352507 |
| C411425 | 5-aminoisoquinolinone | 5-aminoisoquinolinone inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of GSK3B protein] | 23352507 |
| C426745 | 5-iodo-3-(2-azetidinylmethoxy)pyridine | [5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein] | 21715663 |
| C426745 | 5-iodo-3-(2-azetidinylmethoxy)pyridine | [5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein modified form] | 21715663 |
| C426745 | 5-iodo-3-(2-azetidinylmethoxy)pyridine | [5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] which results in increased phosphorylation of GSK3B protein | 21715663 |
| C471843 | 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine | 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine results in decreased activity of GSK3B protein | 15958644 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [ginsenoside Rg2 results in increased phosphorylation of GSK3B protein]" | 22062806 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in decreased activity of GSK3B protein]" | 19620254 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in increased phosphorylation of GSK3B protein]" | 19620254 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSK3B mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSK3B mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose]" | 22180358 |
| C558286 | 6,6'-bis(2,3-dimethoxybenzoyl)-alpha,alpha-trehalose | "6,6'-bis(2,3-dimethoxybenzoyl)-alpha,alpha-trehalose analog results in decreased phosphorylation of GSK3B protein" | 25148938 |
| C558286 | 6,6'-bis(2,3-dimethoxybenzoyl)-alpha,alpha-trehalose | "6,6'-bis(2,3-dimethoxybenzoyl)-alpha,alpha-trehalose analog results in increased expression of GSK3B mRNA" | 25148938 |
| C483321 | 6-bromoindirubin-3'-oxime | 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat inhibits the reaction [TNFRSF10B protein binds to GSK3B protein]] | 28414160 |
| C483321 | 6-bromoindirubin-3'-oxime | 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in decreased expression of GSK3B protein modified form] | 28414160 |
| C483321 | 6-bromoindirubin-3'-oxime | 6-bromoindirubin-3'-oxime results in decreased activity of GSK3B protein | 17991738 |
| C483321 | 6-bromoindirubin-3'-oxime | 6-bromoindirubin-3'-oxime results in increased phosphorylation of GSK3B protein | 19727391 |
| C483321 | 6-bromoindirubin-3'-oxime | Methotrexate promotes the reaction [6-bromoindirubin-3'-oxime results in increased phosphorylation of GSK3B protein] | 19727391 |
| C483321 | 6-bromoindirubin-3'-oxime | 6-bromoindirubin-3'-oxime results in decreased activity of GSK3B protein | 18624906|2297544 |
| C053876 | 6-isopropoxy-9-oxoxanthene-2-carboxylic acid | [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] inhibits the reaction [GSK3B protein binds to AKT1 protein] | 19407222 |
| C053876 | 6-isopropoxy-9-oxoxanthene-2-carboxylic acid | [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] inhibits the reaction [GSK3B protein binds to MAPK1 protein binds to MAPK3 protein] | 19407222 |
| C053876 | 6-isopropoxy-9-oxoxanthene-2-carboxylic acid | [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] promotes the reaction [GSK3B protein binds to CTNNB1 protein] | 19407222 |
| C053876 | 6-isopropoxy-9-oxoxanthene-2-carboxylic acid | [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in decreased phosphorylation of GSK3B protein | 19407222 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of GSK3B protein modified form | 19679878 |
| D000082 | Acetaminophen | Acetaminophen results in increased phosphorylation of GSK3B protein | 22687999|2575261 |
| D000082 | Acetaminophen | GSTM1 gene mutant form inhibits the reaction [Acetaminophen results in increased phosphorylation of GSK3B protein] | 22687999 |
| D000082 | Acetaminophen | PARK2 gene mutant form affects the reaction [Acetaminophen results in increased phosphorylation of GSK3B protein] | 25752611 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of GSK3B mRNA | 16701773 |
| D000082 | Acetaminophen | Acetaminophen results in decreased phosphorylation of GSK3B protein | 26767949 |
| D000082 | Acetaminophen | morin inhibits the reaction [Acetaminophen results in decreased phosphorylation of GSK3B protein] | 26767949 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased phosphorylation of GSK3B protein] | 25246272 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of GSK3B protein] | 24968063 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [phenethyl isothiocyanate results in increased phosphorylation of GSK3B protein] | 25246272 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of GSK3B protein] | 19126599 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Chromium results in decreased phosphorylation of GSK3B protein] | 18569013 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of GSK3B protein] | 27658547 |
| D000242 | Cyclic AMP | GSK3B protein affects the reaction [Deamino Arginine Vasopressin results in increased abundance of Cyclic AMP] | 20056751 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of GSK3B gene | 27153756 |
| D016604 | Aflatoxin B1 | [CYP2A13 protein co-treated with Aflatoxin B1] results in increased phosphorylation of GSK3B protein | 26084420 |
| D016604 | Aflatoxin B1 | MIR138-1 mRNA alternative form inhibits the reaction [[CYP2A13 protein co-treated with Aflatoxin B1] results in increased phosphorylation of GSK3B protein] | 26084420 |
| C046926 | AH 23848 | [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] inhibits the reaction [GSK3B protein binds to AKT1 protein] | 19407222 |
| C046926 | AH 23848 | [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] inhibits the reaction [GSK3B protein binds to MAPK1 protein binds to MAPK3 protein] | 19407222 |
| C046926 | AH 23848 | [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] promotes the reaction [GSK3B protein binds to CTNNB1 protein] | 19407222 |
| C046926 | AH 23848 | [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in decreased phosphorylation of GSK3B protein | 19407222 |
| C000188 | alachlor | [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of GSK3B protein | 19883720 |
| D043582 | 5-alpha-Dihydroprogesterone | 5-alpha-Dihydroprogesterone results in decreased expression of GSK3B protein | 17443805 |
| C120793 | alsterpaullone | alsterpaullone results in decreased activity of GSK3B protein | 12534346 |
| C120793 | alsterpaullone | alsterpaullone results in decreased activity of GSK3B protein | 16055726 |
| D000596 | Amino Acids | Amino Acids inhibits the reaction [KL gene mutant form results in decreased phosphorylation of GSK3B protein] | 25309793 |
| D000596 | Amino Acids | H 1356 inhibits the reaction [Amino Acids inhibits the reaction [KL gene mutant form results in decreased phosphorylation of GSK3B protein]] | 25309793 |
| D015120 | 6-Aminonicotinamide | 6-Aminonicotinamide inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of GSK3B mRNA | 16483693 |
| D000661 | Amphetamine | GSK3B gene mutant form results in increased susceptibility to Amphetamine | 20357757 |
| D000661 | Amphetamine | Amphetamine results in decreased expression of GSK3B protein | 16144542 |
| C030419 | andrographolide | andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of GSK3B protein] | 27475717 |
| D000924 | Anticholesteremic Agents | Anticholesteremic Agents results in decreased phosphorylation of GSK3B protein | 28275691 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in increased expression of GSK3B mRNA | 24449571 |
| C558369 | antrocin | antrocin results in decreased phosphorylation of GSK3B protein | 21158420 |
| C526219 | apple polyphenol extract | apple polyphenol extract results in decreased activity of GSK3B protein | 16968061 |
| C526219 | apple polyphenol extract | apple polyphenol extract results in increased expression of GSK3B protein | 16968061 |
| D016718 | Arachidonic Acid | [SB 216763 results in decreased activity of GSK3B protein] results in decreased susceptibility to [Arachidonic Acid co-treated with Iron] | 19620254 |
| D016718 | Arachidonic Acid | GSK3B protein mutant form results in decreased susceptibility to [Arachidonic Acid co-treated with Iron] | 19620254 |
| C071942 | arctigenin | arctigenin results in decreased phosphorylation of GSK3B protein | 25380086 |
| C071942 | arctigenin | Quercetin promotes the reaction [arctigenin results in decreased phosphorylation of GSK3B protein] | 25380086 |
| D001151 | Arsenic | Arsenic results in increased phosphorylation of GSK3B protein | 22552367 |
| D001151 | Arsenic | Arsenic results in increased phosphorylation of GSK3B protein | 22552367 |
| C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased phosphorylation of GSK3B protein] | 25246272 |
| C006632 | arsenic trioxide | arsenic trioxide inhibits the reaction [sorafenib results in increased phosphorylation of GSK3B protein] | 25416439 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased phosphorylation of GSK3B protein | 25416439 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of GSK3B mRNA | 22521957 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased phosphorylation of and results in increased activity of GSK3B protein | 23949314 |
| C006632 | arsenic trioxide | [arsenic trioxide results in increased phosphorylation of and results in increased activity of GSK3B protein] which results in increased phosphorylation of and results in increased ubiquitination of and results in increased degradation of CCND1 protein | 23949314 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased phosphorylation of GSK3B protein | 21278055|2524627 |
| C006632 | arsenic trioxide | Deoxyglucose inhibits the reaction [arsenic trioxide results in increased phosphorylation of GSK3B protein] | 25246272 |
| C006632 | arsenic trioxide | GSK3B protein affects the susceptibility to arsenic trioxide | 21278055 |
| C006632 | arsenic trioxide | GSK3B protein modified form affects the reaction [arsenic trioxide results in increased expression of CDKN1A protein] | 21278055 |
| C006632 | arsenic trioxide | sorafenib inhibits the reaction [arsenic trioxide results in decreased phosphorylation of GSK3B protein] | 25416439 |
| C006632 | arsenic trioxide | U 0126 inhibits the reaction [arsenic trioxide results in increased phosphorylation of GSK3B protein] | 21278055 |
| C006632 | arsenic trioxide | MAP2K1 protein promotes the reaction [arsenic trioxide results in increased phosphorylation of GSK3B protein] | 21278055 |
| C015001 | arsenite | arsenite metabolite results in increased expression of GSK3B mRNA | 18242949 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in decreased phosphorylation of GSK3B protein" | 17191120 |
| D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of GSK3B protein] | 24675465 |
| D001205 | Ascorbic Acid | Ascorbic Acid results in decreased expression of GSK3B mRNA | 15372504 |
| D001241 | Aspirin | Aspirin results in decreased activity of GSK3B protein | 19966835 |
| D001241 | Aspirin | Aspirin results in decreased phosphorylation of GSK3B protein | 11593435 |
| D001241 | Aspirin | Aspirin results in increased phosphorylation of GSK3B protein | 12813129 |
| D001280 | Atrazine | Atrazine results in increased expression of GSK3B mRNA | 22378314 |
| D001397 | Azoxymethane | Azoxymethane results in increased phosphorylation of GSK3B protein | 20681671 |
| D001397 | Azoxymethane | pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of GSK3B protein] | 20681671 |
| C006680 | baicalein | baicalein results in decreased phosphorylation of GSK3B protein | 22820424 |
| C060988 | baohuoside I | baohuoside I results in decreased phosphorylation of GSK3B protein | 25119583 |
| C487081 | belinostat | belinostat results in increased phosphorylation of GSK3B protein | 23671600 |
| D001554 | Benzene | Benzene analog results in decreased activity of GSK3B protein | 17764934 |
| D001564 | Benzo(a)pyrene | AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of GSK3B mRNA] | 15034205 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of GSK3B mRNA | 15034205 |
| D001564 | Benzo(a)pyrene | GSK3B protein affects the reaction [Benzo(a)pyrene results in increased expression of HK2 mRNA] | 22100782 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of GSK3B mRNA" | 20382639 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GSK3B mRNA" | 19150397 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Estradiol inhibits the reaction [ESR1 protein binds to GSK3B protein]] | 26990689 |
| D001599 | Berberine | Berberine inhibits the reaction [Glucose results in decreased phosphorylation of GSK3B protein] | 23954465 |
| D001599 | Berberine | Berberine results in increased phosphorylation of GSK3B protein | 23954465 |
| D001599 | Berberine | Berberine inhibits the reaction [Dexamethasone results in decreased expression of GSK3B mRNA] | 20462044 |
| D004958 | Estradiol | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Estradiol inhibits the reaction [ESR1 protein binds to GSK3B protein]] | 26990689 |
| D004958 | Estradiol | Estradiol affects the expression of GSK3B mRNA | 22574217 |
| D004958 | Estradiol | Estradiol inhibits the reaction [ESR1 protein binds to GSK3B protein] | 26990689 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of GSK3B protein | 16076840 |
| D004958 | Estradiol | wortmannin inhibits the reaction [Estradiol results in increased phosphorylation of GSK3B protein] | 16076840 |
| D004958 | Estradiol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased phosphorylation of GSK3B protein] | 15845746 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of GSK3B protein | 15845746 |
| D004958 | Estradiol | Progesterone inhibits the reaction [Estradiol results in increased phosphorylation of GSK3B protein] | 15845746 |
| D004958 | Estradiol | Estradiol inhibits the reaction [Progesterone results in decreased expression of GSK3B mRNA] | 17170212 |
| C044887 | beta-methylcholine | beta-methylcholine affects the expression of GSK3B mRNA | 21179406 |
| D001632 | Bibenzyls | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein]]" | 28245986 |
| D001632 | Bibenzyls | Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein] | 28245986 |
| D001632 | Bibenzyls | PARK7 protein affects the reaction [Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein]] | 28245986 |
| D001632 | Bibenzyls | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein]]" | 28245986 |
| D001632 | Bibenzyls | Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein] | 28245986 |
| D001632 | Bibenzyls | PARK7 protein affects the reaction [Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein]] | 28245986 |
| C516541 | BI D1870 | BI D1870 inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| C516541 | BI D1870 | BI D1870 results in decreased phosphorylation of GSK3B protein | 21488662 |
| C528260 | bis(12)-hupyridone | bis(12)-hupyridone results in increased expression of GSK3B protein modified form | 23085120 |
| C577051 | bis(3)-cognitin | "bis(3)-cognitin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased phosphorylation of GSK3B protein]" | 22891246 |
| C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in decreased expression of GSK3B mRNA | 26186136 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I results in decreased activity of GSK3B protein | 16055726 |
| C467001 | bisindolylmaleimide IX | bisindolylmaleimide IX results in decreased activity of GSK3B protein | 16055726 |
| C006780 | bisphenol A | bisphenol A inhibits the reaction [INS1 protein results in increased phosphorylation of GSK3B protein] | 28483554 |
| C006780 | bisphenol A | bisphenol A results in decreased phosphorylation of GSK3B protein | 25637671|2677993 |
| C006780 | bisphenol A | bisphenol A results in increased phosphorylation of GSK3B protein | 26923231 |
| C006780 | bisphenol A | bisphenol A promotes the reaction [Dietary Fats results in decreased phosphorylation of GSK3B protein] | 25112833 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of GSK3B mRNA | 26186136 |
| C006780 | bisphenol A | bisphenol A results in decreased phosphorylation of GSK3B protein | 25112833|2596372 |
| C006780 | bisphenol A | bisphenol A results in increased expression of and results in decreased phosphorylation of GSK3B protein | 25381574 |
| C006780 | bisphenol A | bisphenol A results in increased expression of GSK3B mRNA | 25181051|2538157 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of GSK3B gene | 28505145 |
| C006780 | bisphenol A | Curcumin inhibits the reaction [bisphenol A results in decreased phosphorylation of GSK3B protein] | 25963729 |
| C006780 | bisphenol A | Curcumin inhibits the reaction [bisphenol A results in increased expression of GSK3B mRNA] | 25963729 |
| C006780 | bisphenol A | Curcumin inhibits the reaction [bisphenol A results in increased phosphorylation of and affects the localization of GSK3B protein] | 25963729 |
| C006780 | bisphenol A | Dietary Fats promotes the reaction [bisphenol A results in decreased phosphorylation of GSK3B protein] | 25112833 |
| C006780 | bisphenol A | GSK3B mutant form inhibits the reaction [bisphenol A results in increased phosphorylation of and affects the localization of GSK3B protein] | 25963729|2596372 |
| C006780 | bisphenol A | WNT3A protein affects the reaction [bisphenol A results in increased expression of and results in decreased phosphorylation of GSK3B protein] | 25381574 |
| D001761 | Bleomycin | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein] which results in decreased susceptibility to Bleomycin | 19429264 |
| D001761 | Bleomycin | Bleomycin results in increased phosphorylation of GSK3B protein | 19429264 |
| D001761 | Bleomycin | [Bleomycin results in increased phosphorylation of GSK3B protein] inhibits the reaction [GSK3B protein binds to and results in increased stability of NFKBIA protein] | 19429264 |
| D001786 | Blood Glucose | [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased phosphorylation of GSK3B protein | 24058562 |
| D001786 | Blood Glucose | sodium bisulfide inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased phosphorylation of GSK3B protein] | 24058562 |
| C428117 | BMS 191095 | BMS 191095 results in increased phosphorylation of GSK3B protein | 18212794 |
| D000069286 | Bortezomib | [Bortezomib co-treated with lonafarnib] results in decreased expression of GSK3B protein modified form | 16118318 |
| C050295 | brazilein | brazilein results in decreased expression of GSK3B protein modified form | 23948132 |
| C099813 | bromochloroacetic acid | bromochloroacetic acid affects the expression of GSK3B mRNA | 16460773 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine results in decreased phosphorylation of GSK3B protein | 18552690 |
| C027561 | butylbenzyl phthalate | butylbenzyl phthalate results in increased phosphorylation of GSK3B protein | 22552774 |
| C027561 | butylbenzyl phthalate | HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate results in increased phosphorylation of GSK3B protein] | 22552774 |
| D020122 | tert-Butylhydroperoxide | "3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of GSK3B protein]" | 29128606 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased phosphorylation of GSK3B protein | 29128606 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of GSK3B mRNA | 15336504 |
| D002104 | Cadmium | Cadmium results in increased phosphorylation of GSK3B protein | 22884995 |
| D002104 | Cadmium | CAT protein inhibits the reaction [Cadmium results in increased phosphorylation of GSK3B protein] | 22884995 |
| D002104 | Cadmium | GSK3B mutant form results in decreased susceptibility to Cadmium | 25273023 |
| D002104 | Cadmium | [GSK3B mutant form results in decreased susceptibility to Cadmium] which results in decreased expression of ABCC1 mRNA | 25273023 |
| D002104 | Cadmium | [GSK3B mutant form results in decreased susceptibility to Cadmium] which results in decreased expression of ABCC1 protein | 25273023 |
| D002104 | Cadmium | SOD1 protein inhibits the reaction [Cadmium results in increased phosphorylation of GSK3B protein] | 22884995 |
| D002104 | Cadmium | SOD2 protein inhibits the reaction [Cadmium results in increased phosphorylation of GSK3B protein] | 22884995 |
| D002104 | Cadmium | Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of GSK3B protein] | 19126599 |
| D002104 | Cadmium | Cadmium results in increased phosphorylation of GSK3B protein | 19126599 |
| D002104 | Cadmium | GSK3B protein results in increased susceptibility to Cadmium | 19126599 |
| D002104 | Cadmium | Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of GSK3B protein] | 27658547 |
| D002104 | Cadmium | [Cadmium co-treated with rottlerin] results in decreased expression of GSK3B protein | 27658547 |
| D002104 | Cadmium | GSK3B protein affects the reaction [Cadmium results in increased cleavage of PARP1 protein] | 27658547 |
| D002104 | Cadmium | GSK3B protein affects the reaction [Cadmium results in increased expression of DDIT3 protein] | 27658547 |
| D002104 | Cadmium | GSK3B protein affects the reaction [Cadmium results in increased expression of HMOX1 protein] | 27658547 |
| D002104 | Cadmium | GSK3B protein affects the susceptibility to Cadmium | 27658547 |
| D002104 | Cadmium | Lithium Chloride promotes the reaction [Cadmium results in increased phosphorylation of GSK3B protein] | 27658547 |
| D002104 | Cadmium | rottlerin inhibits the reaction [Cadmium results in increased phosphorylation of GSK3B protein] | 27658547 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein | 28527916 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased phosphorylation of GSK3B protein | 24057571|2511893 |
| D019256 | Cadmium Chloride | ACHE mRNA promotes the reaction [Cadmium Chloride results in increased expression of GSK3B mRNA] | 27377441 |
| D019256 | Cadmium Chloride | [[Cadmium Chloride results in decreased activity of CHRM1 protein] which affects the expression of ACHE mRNA alternative form] which results in increased expression of GSK3B mRNA | 27377441 |
| D019256 | Cadmium Chloride | [Cadmium Chloride results in decreased activity of CHRM1 protein] which results in increased expression of GSK3B mRNA | 27377441 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of GSK3B mRNA | 26026611|2737744 |
| D019256 | Cadmium Chloride | CHRM1 mRNA inhibits the reaction [Cadmium Chloride results in increased expression of GSK3B mRNA] | 27377441 |
| D019256 | Cadmium Chloride | GSK3B mutant form inhibits the reaction [Cadmium Chloride results in increased activity of CASP3 protein] | 26026611 |
| D019256 | Cadmium Chloride | GSK3B mutant form inhibits the reaction [Cadmium Chloride results in increased activity of CASP7 protein] | 26026611 |
| D019256 | Cadmium Chloride | GSK3B mutant form inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased phosphorylation of MAPT protein] | 26026611 |
| D002110 | Caffeine | Caffeine results in increased phosphorylation of GSK3B protein | 21229324 |
| D002110 | Caffeine | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Caffeine results in increased phosphorylation of GSK3B protein] | 21229324 |
| D002110 | Caffeine | Caffeine results in decreased phosphorylation of GSK3B protein | 15126379 |
| D002118 | Calcium | Calcium results in increased phosphorylation of GSK3B protein | 15800129 |
| C059041 | calyculin A | calyculin A promotes the reaction [Lithium Chloride results in increased phosphorylation of GSK3B protein] | 12813129 |
| D002211 | Capsaicin | Capsaicin promotes the reaction [CEBPB protein binds to ATF3 protein binds to GSK3B protein] | 20110283 |
| D002211 | Capsaicin | GSK3B mutant form inhibits the reaction [Capsaicin results in increased expression of GDF15 mRNA] | 20110283 |
| D002215 | Captan | [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of GSK3B protein | 19883720 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of GSK3B mRNA | 24752500 |
| D002248 | Carbon Monoxide | Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of GSK3B protein] | 18037988 |
| D002248 | Carbon Monoxide | Carbon Monoxide results in increased phosphorylation of GSK3B protein | 18845810 |
| D000068579 | Celecoxib | Celecoxib results in decreased phosphorylation of GSK3B protein | 17257745 |
| D000068579 | Celecoxib | GSK3B mutant form inhibits the reaction [Celecoxib results in increased expression of GDF15] | 17257745 |
| D002518 | Ceramides | Ceramides promotes the reaction [IGF1 protein results in decreased phosphorylation of and results in increased activity of GSK3B protein] | 20696185 |
| C019290 | chaetoglobosins | chaetoglobosins results in increased phosphorylation of GSK3B protein | 18040759 |
| C019290 | chaetoglobosins | wortmannin inhibits the reaction [chaetoglobosins results in increased phosphorylation of GSK3B protein] | 18040759 |
| C473711 | Chir 99021 | Chir 99021 affects the phosphorylation of GSK3B protein | 27752740 |
| D048271 | Chitosan | [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of GSK3B protein] | 28732690 |
| C084597 | chlorcyclizine | chlorcyclizine results in decreased expression of GSK3B mRNA | 21058326 |
| D005023 | Ethylene Chlorohydrin | Ethylene Chlorohydrin results in increased expression of GSK3B mRNA | 26962056 |
| D002719 | Chlormethiazole | Chlormethiazole inhibits the reaction [Ethanol results in decreased phosphorylation of GSK3B protein] | 24892905 |
| C007020 | chlorophyllin | "[chlorophyllin affects the reaction [1,2-Dimethylhydrazine results in increased mutagenesis of CTNNB1 gene]] inhibits the reaction [GSK3B protein results in increased phosphorylation of and results in increased ubiquitination of CTNNB1 protein]" | 12628520 |
| C007020 | chlorophyllin | "[chlorophyllin affects the reaction [2-amino-3-methylimidazo(4,5-f)quinoline results in increased mutagenesis of CTNNB1 gene]] inhibits the reaction [GSK3B protein results in increased phosphorylation of and results in increased ubiquitination of CTNNB1 protein]" | 12628520 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in decreased expression of GSK3B mRNA | 18668222 |
| D002784 | Cholesterol | Cholesterol results in increased phosphorylation of GSK3B protein | 28275691 |
| D002784 | Cholesterol | CYP7A1 mRNA inhibits the reaction [Cholesterol results in increased phosphorylation of GSK3B protein] | 28275691 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GSK3B gene | 20938992 |
| D002857 | Chromium | Acetylcysteine inhibits the reaction [Chromium results in decreased phosphorylation of GSK3B protein] | 18569013 |
| D002857 | Chromium | Chromium results in decreased phosphorylation of GSK3B protein | 18569013 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion results in increased phosphorylation of GSK3B protein | 22552367 |
| C045645 | cilostazol | cilostazol affects the phosphorylation of GSK3B protein | 24254769 |
| C045645 | cilostazol | SIRT1 protein affects the reaction [cilostazol affects the phosphorylation of GSK3B protein] | 24254769 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde results in decreased expression of GSK3B mRNA | 28219650 |
| C002471 | cinobufagin | cinobufagin results in increased expression of GSK3B protein modified form | 23164673 |
| C002471 | cinobufagin | GSK3B protein affects the susceptibility to cinobufagin | 23164673 |
| C002471 | cinobufagin | GSK3B protein mutant form inhibits the reaction [cinobufagin results in decreased expression of RELA protein] | 23164673 |
| C002471 | cinobufagin | GSK3B protein mutant form inhibits the reaction [cinobufagin results in increased expression of PARP1 protein modified form] | 23164673 |
| C002471 | cinobufagin | SB 216763 inhibits the reaction [cinobufagin results in increased expression of GSK3B protein modified form] | 23164673 |
| D003024 | Clozapine | Clozapine results in increased phosphorylation of GSK3B protein | 19440698 |
| D003024 | Clozapine | Clozapine results in increased expression of GSK3B protein | 16144542|1935914 |
| D003024 | Clozapine | DRD2 protein affects the reaction [Clozapine results in increased expression of GSK3B protein] | 16144542 |
| C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin affects the phosphorylation of GSK3B protein | 23497794 |
| C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin promotes the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein] | 24658657 |
| C007095 | cobaltiprotoporphyrin | tin protoporphyrin IX inhibits the reaction [cobaltiprotoporphyrin promotes the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein]] | 24658657 |
| C018021 | cobaltous chloride | [lysophosphatidylethanolamine analog co-treated with cobaltous chloride] results in increased phosphorylation of GSK3B protein | 25125499 |
| D003042 | Cocaine | Cocaine results in decreased phosphorylation of and results in increased activity of GSK3B protein | 19328817 |
| D003042 | Cocaine | Cocaine results in increased activity of GSK3B protein | 19328817 |
| D009243 | NAD | GSK3B protein mutant form results in increased abundance of NAD metabolite | 25246272 |
| D009249 | NADP | GSK3B protein mutant form results in increased abundance of NADP metabolite | 25246272 |
| C024989 | coenzyme Q10 | coenzyme Q10 inhibits the reaction [APP protein results in decreased phosphorylation of GSK3B protein] | 22186599 |
| D003078 | Colchicine | Colchicine results in decreased expression of GSK3B mRNA | 18255150 |
| D003078 | Colchicine | Colchicine affects the phosphorylation of and results in increased activity of GSK3B protein | 15979805 |
| D003078 | Colchicine | Lithium inhibits the reaction [Colchicine affects the phosphorylation of and results in increased activity of GSK3B protein] | 15979805 |
| D005576 | Colforsin | Colforsin results in increased phosphorylation of and results in decreased activity of GSK3B protein | 15950778 |
| D003300 | Copper | [Copper binds to Thiosemicarbazones analog] which results in decreased activity of GSK3B protein | 19122148 |
| D003300 | Copper | [NSC 689534 binds to Copper] which results in increased expression of GSK3B mRNA | 20971185 |
| D003300 | Copper | [Thiosemicarbazones binds to Copper] which results in increased expression of GSK3B protein | 20931265 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased expression of GSK3B mRNA | 19549813 |
| D004205 | Cromolyn Sodium | [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of GSK3B protein] | 28732690 |
| D004205 | Cromolyn Sodium | Cromolyn Sodium results in decreased activity of GSK3B protein | 23784744 |
| D003474 | Curcumin | Curcumin inhibits the reaction [IL1B protein results in decreased expression of GSK3B mRNA] | 27645308 |
| D003474 | Curcumin | Curcumin inhibits the reaction [IL1B protein results in increased expression of GSK3B protein] | 27645308 |
| D003474 | Curcumin | Curcumin results in decreased expression of GSK3B mRNA | 27645308 |
| D003474 | Curcumin | Curcumin results in decreased phosphorylation of GSK3B protein | 18790744 |
| D003474 | Curcumin | Curcumin results in increased expression of and results in increased phosphorylation of GSK3B protein | 27645308 |
| D003474 | Curcumin | Curcumin results in increased expression of GSK3B protein | 19573523 |
| D003474 | Curcumin | Curcumin results in decreased phosphorylation of GSK3B protein | 18006147 |
| D003474 | Curcumin | Curcumin inhibits the reaction [bisphenol A results in decreased phosphorylation of GSK3B protein] | 25963729 |
| D003474 | Curcumin | Curcumin inhibits the reaction [bisphenol A results in increased expression of GSK3B mRNA] | 25963729 |
| D003474 | Curcumin | Curcumin inhibits the reaction [bisphenol A results in increased phosphorylation of and affects the localization of GSK3B protein] | 25963729 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Streptozocin results in decreased phosphorylation of GSK3B protein] | 25541178 |
| D003474 | Curcumin | Curcumin results in decreased expression of GSK3B mRNA | 25963729 |
| D003474 | Curcumin | Curcumin results in increased phosphorylation of GSK3B protein | 25963729 |
| C057862 | cyanoginosin LR | cyanoginosin LR results in increased phosphorylation of GSK3B protein | 20421190 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of GSK3B mRNA] | 11007951 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of GSK3B mRNA | 22147139|2556210 |
| D016572 | Cyclosporine | Cyclosporine results in increased phosphorylation of GSK3B protein | 22416070 |
| D016572 | Cyclosporine | [GSK3A protein co-treated with GSK3B protein] affects the reaction [Cyclosporine results in increased expression of SNAI1 protein] | 22416070 |
| D016572 | Cyclosporine | Cyclosporine results in increased phosphorylation of GSK3B protein | 22416070 |
| D003634 | DDT | Acetylcysteine inhibits the reaction [DDT results in increased phosphorylation of GSK3B protein] | 24968063 |
| D003634 | DDT | DDT results in increased phosphorylation of GSK3B protein | 24968063 |
| D003894 | Deamino Arginine Vasopressin | GSK3B protein affects the reaction [Deamino Arginine Vasopressin results in increased abundance of Cyclic AMP] | 20056751 |
| D003676 | Deferoxamine | Deferoxamine inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| D003676 | Deferoxamine | Deferoxamine results in decreased phosphorylation of GSK3B protein | 25246272 |
| C107676 | deguelin | deguelin results in decreased phosphorylation of GSK3B protein | 19336726|2147272 |
| D013759 | Dronabinol | Dronabinol results in decreased phosphorylation of GSK3B protein | 29082320 |
| D013759 | Dronabinol | [Dronabinol results in increased susceptibility to Dronabinol] which results in decreased phosphorylation of GSK3B protein | 29082320 |
| D003847 | Deoxyglucose | Deoxyglucose inhibits the reaction [arsenic trioxide results in increased phosphorylation of GSK3B protein] | 25246272 |
| D003847 | Deoxyglucose | Deoxyglucose inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased phosphorylation of GSK3B protein | 15976193 |
| D003907 | Dexamethasone | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of GSK3B protein | 27475717 |
| D003907 | Dexamethasone | andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of GSK3B protein] | 27475717 |
| D003907 | Dexamethasone | Berberine inhibits the reaction [Dexamethasone results in decreased expression of GSK3B mRNA] | 20462044 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of GSK3B mRNA | 20462044 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of and results in decreased phosphorylation of GSK3B protein | 20501703 |
| D003907 | Dexamethasone | Dexamethasone results in increased ubiquitination of GSK3B protein | 24451375 |
| C028009 | diallyl disulfide | diallyl disulfide results in increased phosphorylation of GSK3B protein | 23663050 |
| C042577 | diallyl trisulfide | diallyl trisulfide results in increased phosphorylation of GSK3B protein | 23663050 |
| C042577 | diallyl trisulfide | diallyl trisulfide results in decreased expression of GSK3B protein | 23453443 |
| D003976 | Diazinon | [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of GSK3B protein | 19883720 |
| D003976 | Diazinon | Diazinon affects the expression of GSK3B mRNA | 22546817 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased phosphorylation of GSK3B protein | 22552774 |
| D003993 | Dibutyl Phthalate | HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate results in increased phosphorylation of GSK3B protein] | 22552774 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of GSK3B mRNA | 21266533 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of GSK3B mRNA | 27594783 |
| D002945 | Cisplatin | Cisplatin results in decreased phosphorylation of GSK3B protein | 21603599|2182100 |
| D002945 | Cisplatin | GSK3B mutant form inhibits the reaction [Cisplatin results in increased expression of LGALS3 protein] | 21821001 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of GSK3B mRNA | 21151649 |
| D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene affects the activity of GSK3B protein | 25386960 |
| D004008 | Diclofenac | Diclofenac affects the expression of GSK3B mRNA | 24752500 |
| C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate affects the expression of GSK3B mRNA | 26924002 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of GSK3B mRNA | 18042831 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of GSK3B mRNA | 24812660|2726046 |
| D004041 | Dietary Fats | Quercetin inhibits the reaction [Dietary Fats results in increased expression of GSK3B mRNA] | 27260466 |
| D004041 | Dietary Fats | resveratrol inhibits the reaction [Dietary Fats results in increased expression of GSK3B mRNA] | 24812660|2726046 |
| D004041 | Dietary Fats | Thioctic Acid inhibits the reaction [Dietary Fats results in increased expression of GSK3B mRNA] | 27260466 |
| D004041 | Dietary Fats | bisphenol A promotes the reaction [Dietary Fats results in decreased phosphorylation of GSK3B protein] | 25112833 |
| D004041 | Dietary Fats | Dietary Fats promotes the reaction [bisphenol A results in decreased phosphorylation of GSK3B protein] | 25112833 |
| D004041 | Dietary Fats | Dietary Fats results in decreased phosphorylation of GSK3B protein | 25112833 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of GSK3B protein] | 28526321 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased phosphorylation of GSK3B protein | 22610992 |
| D004052 | Diethylnitrosamine | CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of GSK3B protein] | 20583210 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine affects the phosphorylation of GSK3B protein | 24535843 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased phosphorylation of GSK3B protein | 20583210 |
| D004052 | Diethylnitrosamine | "5,7-dimethoxyflavone promotes the reaction [Diethylnitrosamine results in increased phosphorylation of GSK3B protein]" | 21554863 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of GSK3B protein modified form | 19931519 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased phosphorylation of GSK3B protein | 21554863 |
| D004052 | Diethylnitrosamine | morin inhibits the reaction [Diethylnitrosamine results in increased expression of GSK3B protein modified form] | 19931519 |
| D019813 | 1,2-Dimethylhydrazine | "[chlorophyllin affects the reaction [1,2-Dimethylhydrazine results in increased mutagenesis of CTNNB1 gene]] inhibits the reaction [GSK3B protein results in increased phosphorylation of and results in increased ubiquitination of CTNNB1 protein]" | 12628520 |
| D004127 | Dimethylhydrazines | [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of GSK3B protein] | 28732690 |
| D004127 | Dimethylhydrazines | Dimethylhydrazines results in increased expression of GSK3B protein | 28732690 |
| C024629 | dimethyl phthalate | dimethyl phthalate results in decreased expression of GSK3B mRNA | 26924002 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of GSK3B mRNA | 17374397 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of GSK3B mRNA | 28219650 |
| D004221 | Disulfiram | Disulfiram results in decreased expression of GSK3B mRNA | 20530235 |
| D016291 | Dizocilpine Maleate | Dizocilpine Maleate results in increased phosphorylation of GSK3B protein | 15877933 |
| D004280 | Dobutamine | GSK3B gene mutant form affects the susceptibility to Dobutamine | 17901358 |
| D007980 | Levodopa | EPO protein inhibits the reaction [Levodopa results in decreased expression of GSK3B protein] | 21683736 |
| D007980 | Levodopa | Levodopa results in decreased expression of GSK3B protein | 21683736 |
| D007980 | Levodopa | Levodopa results in decreased phosphorylation of GSK3B protein | 19786063 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of GSK3B protein | 17339365 |
| D004317 | Doxorubicin | methylselenic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of GSK3B protein] | 17339365 |
| D004317 | Doxorubicin | Selenium inhibits the reaction [Doxorubicin results in increased phosphorylation of GSK3B protein] | 17339365 |
| D004317 | Doxorubicin | Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of GSK3B protein] | 18037988 |
| D004317 | Doxorubicin | Doxorubicin results in decreased phosphorylation of GSK3B protein | 18037988 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of and results in decreased phosphorylation of GSK3B protein" | 28548306 |
| D004365 | Drugs, Chinese Herbal | "PPP2CA protein affects the reaction [Drugs, Chinese Herbal results in decreased phosphorylation of GSK3B protein]" | 28548306 |
| D004656 | Enalapril | Enalapril inhibits the reaction [Isoproterenol results in decreased phosphorylation of GSK3B protein] | 18806606 |
| D004726 | Endosulfan | [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of GSK3B protein | 19883720 |
| C044101 | endotoxin, Escherichia coli | "[endotoxin, Escherichia coli results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of GSK3B protein" | 23755222 |
| C044101 | endotoxin, Escherichia coli | "malvidin promotes the reaction [[endotoxin, Escherichia coli results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of GSK3B protein]" | 23755222 |
| C040996 | enkephalin-Leu, Ala(2)-Arg(6)- | "enkephalin-Leu, Ala(2)-Arg(6)- results in increased phosphorylation of GSK3B protein" | 23651617 |
| C118739 | entinostat | entinostat results in decreased expression of GSK3B mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSK3B mRNA" | 27188386 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased phosphorylation of GSK3B protein | 16968065 |
| C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GSK3B mRNA | 22079256 |
| C007633 | estragole | estragole results in increased phosphorylation of GSK3B protein | 29054680 |
| D000431 | Ethanol | ALDH2 protein inhibits the reaction [Ethanol results in decreased phosphorylation of GSK3B protein] | 19429258 |
| D000431 | Ethanol | [Ethanol co-treated with sodium arsenite] results in increased phosphorylation of GSK3B protein | 26220687 |
| D000431 | Ethanol | Ethanol results in decreased activity of and affects the phosphorylation of GSK3B protein | 26014148 |
| D000431 | Ethanol | Ethanol results in increased phosphorylation of GSK3B protein | 26220687 |
| D000431 | Ethanol | [sodium arsenite co-treated with Ethanol] results in increased phosphorylation of GSK3B protein | 22872060 |
| D000431 | Ethanol | ALDH2 protein inhibits the reaction [Ethanol results in increased phosphorylation of GSK3B protein] | 19332462 |
| D000431 | Ethanol | Chlormethiazole inhibits the reaction [Ethanol results in decreased phosphorylation of GSK3B protein] | 24892905 |
| D000431 | Ethanol | Ethanol results in decreased phosphorylation of GSK3B protein | 18377926|1942925 |
| D000431 | Ethanol | Ethanol results in increased phosphorylation of GSK3B protein | 19332462|2245917 |
| D000431 | Ethanol | NR1H4 gene mutant form inhibits the reaction [Ethanol results in decreased phosphorylation of GSK3B protein] | 25460735 |
| D000431 | Ethanol | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Ethanol results in increased phosphorylation of GSK3B protein] | 28962519 |
| D000431 | Ethanol | [Ethanol results in decreased susceptibility to INS1 protein] which results in increased activity of GSK3B protein | 12700235 |
| D000431 | Ethanol | Ethanol results in increased activity of and results in decreased phosphorylation of GSK3B protein | 12700235 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of GSK3B mRNA | 12655037|1557682 |
| D005013 | Ethosuximide | DKK1 protein inhibits the reaction [Ethosuximide results in increased phosphorylation of GSK3B protein] | 26420483 |
| D005013 | Ethosuximide | Ethosuximide inhibits the reaction [APP protein modified form results in increased expression of GSK3B mRNA] | 26420483 |
| D005013 | Ethosuximide | Ethosuximide results in decreased expression of GSK3B mRNA | 26420483 |
| D005013 | Ethosuximide | Ethosuximide results in increased phosphorylation of GSK3B protein | 26420483 |
| D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in increased expression of GSK3B mRNA | 23649840 |
| D005038 | Ethylnitrosourea | Ethylnitrosourea results in decreased expression of GSK3B protein | 28549617 |
| D005047 | Etoposide | BCL2 protein affects the reaction [[Etoposide results in increased activity of GSK3B protein] which results in increased activity of CASP3 protein] | 19408126 |
| D005047 | Etoposide | Etoposide results in increased activity of GSK3B protein | 19408126 |
| D005047 | Etoposide | [Etoposide results in increased activity of GSK3B protein] which results in increased activity of CASP3 protein | 19408126 |
| D005054 | Eugenol | Eugenol results in increased expression of GSK3B mRNA | 17374397 |
| D018683 | Excitatory Amino Acid Agents | [resveratrol co-treated with Excitatory Amino Acid Agents] results in increased phosphorylation of and results in decreased activity of GSK3B protein | 20542495 |
| D018690 | Excitatory Amino Acid Agonists | Excitatory Amino Acid Agonists affects the phosphorylation of GSK3B protein | 24675465 |
| D018690 | Excitatory Amino Acid Agonists | resveratrol inhibits the reaction [Excitatory Amino Acid Agonists affects the phosphorylation of GSK3B protein] | 24675465 |
| D018690 | Excitatory Amino Acid Agonists | Ascorbic Acid inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of GSK3B protein] | 24675465 |
| D018690 | Excitatory Amino Acid Agonists | Excitatory Amino Acid Agonists affects the phosphorylation of and results in increased activity of GSK3B protein | 24675465 |
| D018690 | Excitatory Amino Acid Agonists | GSK3B protein results in increased susceptibility to Excitatory Amino Acid Agonists | 24675465 |
| D018690 | Excitatory Amino Acid Agonists | resveratrol inhibits the reaction [Excitatory Amino Acid Agonists affects the phosphorylation of GSK3B protein] | 24675465 |
| D018690 | Excitatory Amino Acid Agonists | SB 216763 inhibits the reaction [Excitatory Amino Acid Agonists affects the phosphorylation of GSK3B protein] | 24675465 |
| C020748 | ferrous sulfate | ferrous sulfate results in increased phosphorylation of GSK3B protein | 19608791 |
| C082360 | fipronil | fipronil results in decreased phosphorylation of GSK3B protein | 21296133 |
| C082360 | fipronil | GSK3B protein affects the susceptibility to fipronil | 21296133 |
| C082360 | fipronil | kenpaullone inhibits the reaction [fipronil results in decreased phosphorylation of GSK3B protein] | 21296133 |
| C082360 | fipronil | Lithium Chloride inhibits the reaction [fipronil results in decreased phosphorylation of GSK3B protein] | 21296133 |
| D005473 | Fluoxetine | Fluoxetine results in increased expression of GSK3B protein | 19359144 |
| D005492 | Folic Acid | Folic Acid results in increased expression of GSK3B mRNA | 25006883 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GSK3B gene | 20938992 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of GSK3B mRNA | 23649840 |
| C058728 | fosbretabulin | fosbretabulin results in decreased expression of GSK3B protein modified form | 18434188 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of GSK3B protein modified form]] | 23170834 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [gypenoside analog results in increased phosphorylation of GSK3B protein] | 24726523 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Phytoestrogens results in increased phosphorylation of GSK3B protein] | 24726523 |
| C000599091 | fumosorinone | fumosorinone results in increased phosphorylation of GSK3B protein | 25796170 |
| C052659 | gambogic acid | gambogic acid results in decreased activity of GSK3B protein | 19433130 |
| C056507 | gemcitabine | gemcitabine results in increased phosphorylation of GSK3B protein | 16570353 |
| D019833 | Genistein | Genistein results in decreased phosphorylation of GSK3B protein | 18431742 |
| C007845 | gingerol | gingerol inhibits the reaction [IL1B protein results in increased expression of GSK3B protein] | 27645308 |
| C007845 | gingerol | gingerol inhibits the reaction [IL1B protein results in increased phosphorylation of GSK3B protein] | 27645308 |
| C007845 | gingerol | gingerol results in increased expression of GSK3B protein | 27645308 |
| C007845 | gingerol | GSK3B protein affects the reaction [gingerol results in increased expression of GDF15 protein] | 18058799 |
| C007845 | gingerol | gingerol results in increased phosphorylation of GSK3B protein | 26498061 |
| C007845 | gingerol | GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA mRNA] | 26498061 |
| C007845 | gingerol | GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA protein] | 26498061 |
| C007845 | gingerol | GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG mRNA] | 26498061 |
| C007845 | gingerol | GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG protein] | 26498061 |
| C007845 | gingerol | GSK3B protein results in increased susceptibility to gingerol | 26498061 |
| C049864 | ginsenoside Re | ginsenoside Re results in increased phosphorylation of GSK3B protein | 17885204 |
| C026474 | ginsenoside Rg2 | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [ginsenoside Rg2 results in increased phosphorylation of GSK3B protein]" | 22062806 |
| C026474 | ginsenoside Rg2 | ginsenoside Rg2 results in increased phosphorylation of GSK3B protein | 22062806 |
| C026474 | ginsenoside Rg2 | [[ginsenoside Rg2 results in increased phosphorylation of GSK3B protein] co-treated with [ginsenoside Rg2 results in increased expression of NR0B2 mRNA]] results in decreased chemical synthesis of Glucose | 22062806 |
| D005947 | Glucose | Berberine inhibits the reaction [Glucose results in decreased phosphorylation of GSK3B protein] | 23954465 |
| D005947 | Glucose | [[ginsenoside Rg2 results in increased phosphorylation of GSK3B protein] co-treated with [ginsenoside Rg2 results in increased expression of NR0B2 mRNA]] results in decreased chemical synthesis of Glucose | 22062806 |
| D005947 | Glucose | Glucose results in decreased phosphorylation of GSK3B protein | 23954465 |
| D005947 | Glucose | Glucose results in increased phosphorylation of GSK3B protein | 23690508 |
| D005947 | Glucose | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose]" | 22180358 |
| D005947 | Glucose | [resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose | 22180358 |
| D005947 | Glucose | Glucose results in decreased phosphorylation of and results in increased activity of GSK3B protein | 18004065 |
| D005947 | Glucose | Glucose results in decreased phosphorylation of GSK3B protein | 26054749 |
| D005947 | Glucose | Simvastatin inhibits the reaction [Glucose results in decreased phosphorylation of and results in increased activity of GSK3B protein] | 18004065 |
| D005947 | Glucose | [INS protein co-treated with Glucose] results in decreased expression of GSK3B mRNA | 22634610 |
| D005947 | Glucose | [INS protein co-treated with Glucose] results in increased expression of GSK3B mRNA | 22634610 |
| D005978 | Glutathione | GSK3B protein mutant form results in increased abundance of Glutathione | 25246272 |
| C474918 | gypenoside | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [gypenoside analog results in increased phosphorylation of GSK3B protein] | 24726523 |
| C474918 | gypenoside | fulvestrant inhibits the reaction [gypenoside analog results in increased phosphorylation of GSK3B protein] | 24726523 |
| C474918 | gypenoside | gypenoside analog results in increased phosphorylation of GSK3B protein | 24726523 |
| C411572 | H 1356 | H 1356 inhibits the reaction [Amino Acids inhibits the reaction [KL gene mutant form results in decreased phosphorylation of GSK3B protein]] | 25309793 |
| D006220 | Haloperidol | DRD2 protein affects the reaction [Haloperidol results in increased expression of GSK3B protein] | 16144542 |
| D006220 | Haloperidol | Haloperidol results in increased expression of GSK3B mRNA | 19359144 |
| D006220 | Haloperidol | Haloperidol results in increased expression of GSK3B protein | 16144542|1935914 |
| D006220 | Haloperidol | Haloperidol results in increased phosphorylation of and results in decreased activity of GSK3B protein | 19328817 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in decreased activity of GSK3B protein | 16679308 |
| D006581 | Hexachlorobenzene | [Hexachlorobenzene results in decreased activity of GSK3B protein] which results in decreased expression of CDH1 protein | 16679308 |
| D017313 | Fenretinide | 6-Aminonicotinamide inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| D017313 | Fenretinide | Acetylcysteine inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| D017313 | Fenretinide | BI D1870 inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| D017313 | Fenretinide | Deferoxamine inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| D017313 | Fenretinide | Deoxyglucose inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| D017313 | Fenretinide | Fenretinide results in increased phosphorylation of GSK3B protein | 25246272 |
| D017313 | Fenretinide | GSK3B protein mutant form inhibits the reaction [Fenretinide results in increased expression of HMOX1 protein] | 25246272 |
| D017313 | Fenretinide | GSK3B protein mutant form inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| D017313 | Fenretinide | S-ethyl glutathione inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| D017313 | Fenretinide | U 0126 inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| D017313 | Fenretinide | Fenretinide results in decreased expression of GSK3B mRNA | 28973697 |
| D012701 | Serotonin | Serotonin results in increased phosphorylation of GSK3B protein | 20190034 |
| C062018 | HU 211 | HU 211 results in decreased phosphorylation of GSK3B protein | 19509271 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of GSK3B mRNA | 21179406 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased phosphorylation of GSK3B protein | 20302854 |
| D006861 | Hydrogen Peroxide | Mycophenolic Acid inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of GSK3B protein] | 20302854 |
| D006861 | Hydrogen Peroxide | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [5-aminoisoquinolinone inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of GSK3B protein]] | 23352507 |
| D006861 | Hydrogen Peroxide | 5-aminoisoquinolinone inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of GSK3B protein] | 23352507 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased phosphorylation of GSK3B protein | 23352507 |
| D004441 | Ecdysterone | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ecdysterone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of and results in decreased activity of GSK3B protein]] | 26048653 |
| D004441 | Ecdysterone | Ecdysterone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of and results in decreased activity of GSK3B protein] | 26048653 |
| C107079 | hymenialdisine | hymenialdisine results in decreased activity of GSK3B protein | 21615147 |
| C477872 | IC 87114 | IC 87114 results in decreased phosphorylation of GSK3B protein | 16179367 |
| D007093 | Imidazoles | Imidazoles analog results in decreased activity of GSK3B protein | 17764934 |
| C474021 | indirubin-3'-monoxime | indirubin-3'-monoxime results in decreased activity of GSK3B protein | 12534346 |
| D007213 | Indomethacin | Indomethacin results in increased expression of GSK3B mRNA | 18299717 |
| D007501 | Iron | [SB 216763 results in decreased activity of GSK3B protein] results in decreased susceptibility to [Arachidonic Acid co-treated with Iron] | 19620254 |
| D007501 | Iron | GSK3B protein mutant form results in decreased susceptibility to [Arachidonic Acid co-treated with Iron] | 19620254 |
| D015056 | 1-Methyl-3-isobutylxanthine | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of GSK3B protein | 27475717 |
| D015056 | 1-Methyl-3-isobutylxanthine | andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of GSK3B protein] | 27475717 |
| D007545 | Isoproterenol | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in decreased phosphorylation of GSK3B protein] | 18806606 |
| D007545 | Isoproterenol | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in increased phosphorylation of GSK3B protein] | 16716347 |
| D007545 | Isoproterenol | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one promotes the reaction [Isoproterenol results in increased phosphorylation of GSK3B protein] | 15951400 |
| D007545 | Isoproterenol | Enalapril inhibits the reaction [Isoproterenol results in decreased phosphorylation of GSK3B protein] | 18806606 |
| D007545 | Isoproterenol | Isoproterenol results in decreased phosphorylation of GSK3B protein | 18806606 |
| D007545 | Isoproterenol | Isoproterenol results in increased phosphorylation of GSK3B protein | 15951400|1671634 |
| C053401 | kahweol | kahweol results in increased phosphorylation of GSK3B protein | 27424123 |
| D007608 | Kainic Acid | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [Kainic Acid results in decreased phosphorylation of GSK3B protein]" | 25453207 |
| D007608 | Kainic Acid | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione promotes the reaction [Valproic Acid inhibits the reaction [Kainic Acid results in decreased phosphorylation of GSK3B protein]]" | 25453207 |
| D007608 | Kainic Acid | Kainic Acid results in decreased activity of GSK3B protein | 18619545 |
| D007608 | Kainic Acid | Kainic Acid results in decreased phosphorylation of GSK3B protein | 25453207 |
| D007608 | Kainic Acid | Valproic Acid inhibits the reaction [Kainic Acid results in decreased phosphorylation of GSK3B protein] | 25453207 |
| C510621 | KCC 009 | KCC 009 results in decreased expression of GSK3B protein | 16170020 |
| C510621 | KCC 009 | KCC 009 results in decreased phosphorylation of and results in increased activity of GSK3B protein | 16170020 |
| C119620 | kenpaullone | kenpaullone inhibits the reaction [fipronil results in decreased phosphorylation of GSK3B protein] | 21296133 |
| C119620 | kenpaullone | kenpaullone results in decreased activity of GSK3B protein | 12534346|2111172 |
| C119620 | kenpaullone | kenpaullone results in decreased phosphorylation of GSK3B protein | 17993264 |
| C119620 | kenpaullone | kenpaullone results in decreased activity of GSK3B protein | 18624906|2297544 |
| D007649 | Ketamine | Ketamine results in decreased phosphorylation of GSK3B protein | 17952604 |
| C063302 | KN 62 | KN 62 results in decreased activity of GSK3B protein | 10998351 |
| C073601 | KT 5823 | KT 5823 results in decreased activity of GSK3B protein | 12534346 |
| D007854 | Lead | Lead affects the splicing of GSK3B mRNA | 28903495 |
| C008261 | lead acetate | lead acetate results in increased phosphorylation of GSK3B protein | 27012722 |
| D044243 | Linoleic Acids, Conjugated | "Linoleic Acids, Conjugated results in decreased phosphorylation of GSK3B protein" | 19800873 |
| D044243 | Linoleic Acids, Conjugated | "Linoleic Acids, Conjugated results in increased activity of GSK3B protein" | 19800873 |
| D008070 | Lipopolysaccharides | fulvestrant inhibits the reaction [notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of GSK3B protein modified form]] | 23170834 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of GSK3B protein modified form | 23170834 |
| D008070 | Lipopolysaccharides | notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of GSK3B protein modified form] | 23170834 |
| D008070 | Lipopolysaccharides | wortmannin inhibits the reaction [notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of GSK3B protein modified form]] | 23170834 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased phosphorylation of GSK3B protein | 18047562 |
| D008070 | Lipopolysaccharides | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of GSK3B protein] | 18047562 |
| D008094 | Lithium | Lithium results in decreased activity of GSK3B protein | 19932742 |
| D008094 | Lithium | Lithium inhibits the reaction [GSK3B protein binds to TP53 protein] | 15475000 |
| D008094 | Lithium | Lithium promotes the reaction [sodium arsenite results in increased phosphorylation of GSK3B protein] | 17849503 |
| D008094 | Lithium | Lithium results in decreased activity of GSK3B protein | 10998351 |
| D008094 | Lithium | Lithium results in increased phosphorylation of GSK3B protein | 15475000|1944069 |
| D008094 | Lithium | Magnesium affects the reaction [Lithium results in decreased activity of GSK3B protein] | 10998351 |
| D008094 | Lithium | Lithium results in decreased activity of GSK3B protein | 19621015 |
| D008094 | Lithium | [Lithium results in decreased activity of GSK3B protein] which results in increased activity of MTOR protein | 17921520 |
| D008094 | Lithium | [Lithium results in decreased activity of GSK3B protein] which results in increased activity of NFE2L2 protein | 18619545 |
| D008094 | Lithium | Lithium results in increased phosphorylation of and results in decreased activity of GSK3B protein | 19328817 |
| D008094 | Lithium | Lithium results in decreased activity of GSK3B protein | 16288908 |
| D008094 | Lithium | Lithium results in decreased phosphorylation of GSK3B protein | 25433145 |
| D008094 | Lithium | Lithium results in increased expression of GSK3B mRNA | 19359144 |
| D008094 | Lithium | Lithium results in increased expression of GSK3B protein | 18296634|1935914 |
| D008094 | Lithium | Lithium results in increased phosphorylation of and results in decreased activity of GSK3B protein | 15950778|2171190 |
| D008094 | Lithium | Lithium results in increased phosphorylation of GSK3B protein | 18296634 |
| D008094 | Lithium | Lithium inhibits the reaction [Colchicine affects the phosphorylation of and results in increased activity of GSK3B protein] | 15979805 |
| D008094 | Lithium | Lithium results in decreased activity of GSK3B protein | 14534419|1792152 |
| D018021 | Lithium Chloride | Lithium Chloride results in decreased activity of GSK3B protein | 19486905 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of SCN9A mRNA | 19486905 |
| D018021 | Lithium Chloride | CTNNB1 protein affects the reaction [[Lithium Chloride results in decreased activity of GSK3B protein] which results in decreased expression of CDH11 protein] | 19274078 |
| D018021 | Lithium Chloride | GSK3B protein mutant form inhibits the reaction [Lithium Chloride results in decreased expression of and results in decreased activity of ACHE protein] | 22944069 |
| D018021 | Lithium Chloride | GSK3B protein mutant form inhibits the reaction [Lithium Chloride results in increased degradation of ACHE protein] | 22944069 |
| D018021 | Lithium Chloride | Lithium Chloride inhibits the reaction [fipronil results in decreased phosphorylation of GSK3B protein] | 21296133 |
| D018021 | Lithium Chloride | Lithium Chloride promotes the reaction [quinocetone affects the phosphorylation of and results in decreased activity of GSK3B protein] | 28343033 |
| D018021 | Lithium Chloride | Lithium Chloride results in decreased activity of and results in increased phosphorylation of GSK3B protein | 22493441 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of and results in increased phosphorylation of GSK3B protein] which results in increased expression of and results in increased phosphorylation of CTNNB1 protein | 22493441 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of and results in increased phosphorylation of GSK3B protein] which results in increased expression of EGFR mRNA | 22493441 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of and results in increased phosphorylation of GSK3B protein] which results in increased expression of EGFR protein | 22493441 |
| D018021 | Lithium Chloride | Lithium Chloride results in decreased activity of GSK3B protein | 19101580|1927407 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of GSK3B protein] inhibits the reaction [Sirolimus results in decreased expression of CCND1 protein] | 15753396 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of GSK3B protein] which results in decreased expression of CDH11 mRNA | 19274078 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of GSK3B protein] which results in decreased expression of CDH11 protein | 19274078 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of HSPA1A protein alternative form | 20090934 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of STARD7 mRNA | 19679347 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of STARD7 protein | 19679347 |
| D018021 | Lithium Chloride | Lithium Chloride results in decreased expression of and results in increased phosphorylation of GSK3B protein | 26990689 |
| D018021 | Lithium Chloride | Lithium Chloride results in decreased phosphorylation of GSK3B protein | 20093106 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased expression of and results in increased phosphorylation of and results in decreased activity of GSK3B protein | 19196980 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased expression of GSK3B protein modified form | 22944069 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein | 17868649|1967934 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased phosphorylation of GSK3B protein | 18830594|2069614 |
| D018021 | Lithium Chloride | PIK3CA protein affects the reaction [Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] | 19196980 |
| D018021 | Lithium Chloride | Lithium Chloride inhibits the reaction [Okadaic Acid affects the phosphorylation of GSK3B protein] | 27050422 |
| D018021 | Lithium Chloride | Lithium Chloride inhibits the reaction [perfluorooctane sulfonic acid results in decreased phosphorylation of GSK3B protein] | 27018151 |
| D018021 | Lithium Chloride | Lithium Chloride results in decreased activity of GSK3B protein | 15364539|1558566 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of AHR mRNA | 21498875 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of AXIN2 mRNA | 21498875 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein | 19440036|1958239 |
| D018021 | Lithium Chloride | [Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] which results in decreased expression of SNAI1 protein | 19440036 |
| D018021 | Lithium Chloride | [Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased localization of CTNNB1 protein | 19582394 |
| D018021 | Lithium Chloride | [[Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased localization of CTNNB1 protein] which results in increased expression of GIP mRNA | 19582394 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased phosphorylation of GSK3B protein | 27018151 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased stability of GSK3B protein | 19448134 |
| D018021 | Lithium Chloride | calyculin A promotes the reaction [Lithium Chloride results in increased phosphorylation of GSK3B protein] | 12813129 |
| D018021 | Lithium Chloride | Lithium Chloride affects the phosphorylation of GSK3B protein | 21364661 |
| D018021 | Lithium Chloride | Lithium Chloride inhibits the reaction [manganese chloride results in decreased phosphorylation of and results in increased activity of GSK3B protein] | 24464479 |
| D018021 | Lithium Chloride | Lithium Chloride inhibits the reaction [sevoflurane results in decreased phosphorylation of GSK3B protein] | 20807582 |
| D018021 | Lithium Chloride | Lithium Chloride promotes the reaction [Cadmium results in increased phosphorylation of GSK3B protein] | 27658547 |
| D018021 | Lithium Chloride | Lithium Chloride results in decreased activity of GSK3B protein | 15247282|1897223 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of GSK3B protein] inhibits the reaction [manganese chloride results in increased phosphorylation of MAPT protein] | 20937724 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein | 18972237 |
| D018021 | Lithium Chloride | [[Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein] which affects the expression of GJA1 protein | 18972237 |
| D018021 | Lithium Chloride | Lithium Chloride results in decreased expression of GSK3B mRNA | 18932008 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein | 12813129|2645918 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased phosphorylation of GSK3B protein | 23651617|2765854 |
| D018021 | Lithium Chloride | Lithium Chloride results in decreased activity of [GSK3A protein binds to GSK3B protein] | 16076840 |
| D018021 | Lithium Chloride | Lithium Chloride results in decreased activity of GSK3B protein | 16055726|1721070 |
| D018021 | Lithium Chloride | [Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 | 23872260 |
| D008095 | Lithocholic Acid | Lithocholic Acid results in increased phosphorylation of and results in decreased activity of GSK3B protein | 20512997 |
| C115354 | lonafarnib | [Bortezomib co-treated with lonafarnib] results in decreased expression of GSK3B protein modified form | 16118318 |
| D019808 | Losartan | Losartan inhibits the reaction [AGT protein modified form results in increased phosphorylation of GSK3B protein] | 22982863 |
| D008148 | Lovastatin | Lovastatin results in decreased phosphorylation of GSK3B protein | 17234346 |
| D008148 | Lovastatin | Lovastatin results in increased phosphorylation of GSK3B protein | 19741129 |
| C010480 | lupeol | lupeol binds to GSK3B protein | 18222664 |
| C008301 | lysophosphatidylethanolamine | [lysophosphatidylethanolamine analog co-treated with cobaltous chloride] results in increased phosphorylation of GSK3B protein | 25125499 |
| D008274 | Magnesium | Magnesium affects the reaction [Lithium results in decreased activity of GSK3B protein] | 10998351 |
| D058185 | Magnetite Nanoparticles | Magnetite Nanoparticles results in decreased expression of GSK3B mRNA | 24525745 |
| D058185 | Magnetite Nanoparticles | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GSK3B mRNA | 21641980 |
| D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] affects the expression of GSK3B mRNA | 26378955 |
| D008294 | Malathion | Malathion results in increased expression of GSK3B mRNA | 25449180 |
| D008298 | Maleates | Maleates results in decreased phosphorylation of GSK3B protein | 21976531 |
| C065861 | malvidin | "malvidin promotes the reaction [[endotoxin, Escherichia coli results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of GSK3B protein]" | 23755222 |
| C013099 | mancozeb | [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of GSK3B protein | 19883720 |
| D008344 | Maneb | [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of GSK3B protein | 19883720 |
| C025340 | manganese chloride | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride results in decreased phosphorylation of GSK3B protein] | 20937724 |
| C025340 | manganese chloride | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride results in increased activity of GSK3B protein] | 20937724 |
| C025340 | manganese chloride | GSK3B protein affects the reaction [manganese chloride results in increased phosphorylation of MAPT protein] | 20937724 |
| C025340 | manganese chloride | Lithium Chloride inhibits the reaction [manganese chloride results in decreased phosphorylation of and results in increased activity of GSK3B protein] | 24464479 |
| C025340 | manganese chloride | [Lithium Chloride results in decreased activity of GSK3B protein] inhibits the reaction [manganese chloride results in increased phosphorylation of MAPT protein] | 20937724 |
| C025340 | manganese chloride | manganese chloride results in decreased phosphorylation of and results in increased activity of GSK3B protein | 24464479 |
| C025340 | manganese chloride | manganese chloride results in decreased phosphorylation of GSK3B protein | 20937724 |
| C025340 | manganese chloride | manganese chloride results in increased activity of GSK3B protein | 20937724 |
| C078290 | manzamine A | manzamine A results in decreased activity of GSK3B protein | 22050263 |
| D008550 | Melatonin | Melatonin inhibits the reaction [wortmannin results in decreased expression of GSK3B protein modified form] | 15842767 |
| D008627 | Mercuric Chloride | GSK3B protein promotes the reaction [Mercuric Chloride results in increased activity of BAX protein] | 22785175 |
| D008627 | Mercuric Chloride | GSK3B protein promotes the reaction [Mercuric Chloride results in increased cleavage of CASP3 protein] | 22785175 |
| D008687 | Metformin | Metformin results in increased phosphorylation of GSK3B protein | 21054339 |
| D008701 | Methapyrilene | Methapyrilene results in increased expression of GSK3B mRNA | 16393664 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GSK3B gene | 20938992 |
| D008727 | Methotrexate | Methotrexate promotes the reaction [6-bromoindirubin-3'-oxime results in increased phosphorylation of GSK3B protein] | 19727391 |
| C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "GSK3B protein mutant form inhibits the reaction [methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased expression of HMOX1 protein]" | 25246272 |
| C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "GSK3B protein mutant form inhibits the reaction [methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased phosphorylation of GSK3B protein]" | 25246272 |
| C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased phosphorylation of GSK3B protein" | 25246272 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of GSK3B mRNA | 28001369 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of GSK3B mRNA | 28001369 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of GSK3B mRNA | 20061341 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased phosphorylation of and results in increased activity of GSK3B protein | 28821999 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased phosphorylation of GSK3B protein | 29258870 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased phosphorylation of GSK3B protein | 28736149 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of GSK3B mRNA | 23649840 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GSK3B mRNA" | 19285098|2018815 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GSK3B protein" | 19285098 |
| D008770 | Methylnitrosourea | [Methylnitrosourea co-treated with Testosterone] results in decreased expression of GSK3B protein | 25164625 |
| D008770 | Methylnitrosourea | Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in decreased expression of GSK3B protein] | 25164625 |
| D015655 | 1-Methyl-4-phenylpyridinium | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IGF1 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of GSK3B protein]] | 20064577 |
| D015655 | 1-Methyl-4-phenylpyridinium | IGF1 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of GSK3B protein] | 20064577 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in decreased phosphorylation of GSK3B protein | 22891246 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in increased phosphorylation of and results in decreased activity of GSK3B protein | 26048653 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in increased phosphorylation of GSK3B protein | 20064577 |
| D015655 | 1-Methyl-4-phenylpyridinium | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of GSK3B protein] | 20064577 |
| D015655 | 1-Methyl-4-phenylpyridinium | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ecdysterone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of and results in decreased activity of GSK3B protein]] | 26048653 |
| D015655 | 1-Methyl-4-phenylpyridinium | Ecdysterone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of and results in decreased activity of GSK3B protein] | 26048653 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased phosphorylation of GSK3B protein" | 22891246|2391187 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased phosphorylation of GSK3B protein]" | 23911879 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "bis(3)-cognitin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased phosphorylation of GSK3B protein]" | 22891246 |
| C008493 | methylselenic acid | methylselenic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of GSK3B protein] | 17339365 |
| C008493 | methylselenic acid | methylselenic acid results in decreased phosphorylation of GSK3B protein | 17339365 |
| D008777 | Methyltestosterone | Methyltestosterone results in decreased expression of GSK3B mRNA | 29191790 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Progesterone results in increased phosphorylation of GSK3B protein] | 16882987 |
| D008911 | Minocycline | Minocycline results in increased phosphorylation of GSK3B protein | 15569265 |
| C010052 | mizoribine | mizoribine inhibits the reaction [Puromycin Aminonucleoside results in increased phosphorylation of GSK3B protein] | 20502051 |
| C016599 | mono-(2-ethylhexyl)phthalate | mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of GSK3B protein] | 28526321 |
| C008542 | monodansylcadaverine | monodansylcadaverine results in decreased expression of GSK3B protein | 16170020 |
| C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of GSK3B mRNA | 26924002 |
| C008548 | morin | morin inhibits the reaction [Acetaminophen results in decreased phosphorylation of GSK3B protein] | 26767949 |
| C008548 | morin | morin inhibits the reaction [Diethylnitrosamine results in increased expression of GSK3B protein modified form] | 19931519 |
| D009020 | Morphine | Morphine results in increased expression of GSK3B protein modified form | 20600172 |
| D009020 | Morphine | Naloxone inhibits the reaction [Morphine results in increased expression of GSK3B protein modified form] | 20600172 |
| D009020 | Morphine | GSK3B protein results in decreased activity of Morphine | 19966058 |
| D009020 | Morphine | Morphine results in increased phosphorylation of GSK3B protein | 19966058 |
| D009020 | Morphine | "N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Morphine results in increased phosphorylation of GSK3B protein]" | 19966058 |
| D009173 | Mycophenolic Acid | Mycophenolic Acid inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of GSK3B protein] | 20302854 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Caffeine results in increased phosphorylation of GSK3B protein] | 21229324 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein]" | 21715663 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein modified form]" | 21715663 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] inhibits the reaction [Okadaic Acid results in increased phosphorylation of MAPT protein]" | 21715663 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CCNB1 protein]" | 20540935 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CCND1 protein]" | 20540935 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CCNE1 protein]" | 20540935 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CDK2 protein]" | 20540935 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CDK4 protein]" | 20540935 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of BAX protein]" | 20540935 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of CASP3 protein]" | 20540935 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of CASP9 protein]" | 20540935 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] which results in decreased susceptibility to Okadaic Acid" | 21715663 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] which results in decreased susceptibility to Proadifen" | 22683934 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] which results in increased susceptibility to troglitazone" | 20540935 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein" | 16202587 |
| C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein" | 20540935|2171566 |
| C064769 | N-acetylsphingosine | GSK3B mutant form inhibits the reaction [N-acetylsphingosine results in increased expression of LGALS3 protein] | 21821001 |
| C064769 | N-acetylsphingosine | N-acetylsphingosine results in decreased phosphorylation of GSK3B protein | 21821001 |
| D009270 | Naloxone | Naloxone inhibits the reaction [Morphine results in increased expression of GSK3B protein modified form] | 20600172 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon affects the expression of GSK3B mRNA" | 23845593 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of GSK3B mRNA" | 25554681 |
| C000621033 | napabucasin | napabucasin results in decreased expression of GSK3B mRNA | 25605917 |
| D009288 | Naproxen | Naproxen results in decreased activity of GSK3B protein | 23784744 |
| C524653 | nectandrin-B | nectandrin-B results in increased phosphorylation of GSK3B protein | 27511913 |
| C524653 | nectandrin-B | GSK3B protein inhibits the reaction [nectandrin-B results in increased expression of GCLC mRNA] | 27511913 |
| C524653 | nectandrin-B | GSK3B protein inhibits the reaction [nectandrin-B results in increased expression of GCLC protein] | 27511913 |
| D009355 | Neomycin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Neomycin results in increased phosphorylation of GSK3B protein] | 15800129 |
| D009355 | Neomycin | Neomycin results in increased phosphorylation of GSK3B protein | 15800129 |
| C022838 | nickel chloride | nickel chloride promotes the reaction [Tretinoin results in increased phosphorylation of GSK3B protein] | 25614230 |
| C022838 | nickel chloride | [nickel chloride results in increased phosphorylation of AKT1 protein] which results in decreased activity of and results in increased phosphorylation of GSK3B protein | 21837363 |
| C022838 | nickel chloride | nickel chloride affects the expression of GSK3B mRNA | 22546817 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of GSK3B mRNA | 17374397 |
| D009534 | Niclosamide | Niclosamide results in decreased expression of GSK3B mRNA | 22576131 |
| D009538 | Nicotine | [Nicotine results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of GSK3B protein | 12511591 |
| C012655 | nimesulide | nimesulide results in decreased activity of GSK3B protein | 16331303 |
| D009583 | Nitrofurazone | Nitrofurazone binds to GSK3B protein | 18222664 |
| C562238 | N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide | "ILK protein inhibits the reaction [N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide results in decreased phosphorylation of GSK3B protein]" | 21823616 |
| C562238 | N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide | "N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide results in decreased phosphorylation of GSK3B protein" | 21823616 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | "N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Morphine results in increased phosphorylation of GSK3B protein]" | 19966058 |
| C072936 | notoginsenoside R1 | fulvestrant inhibits the reaction [notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of GSK3B protein modified form]] | 23170834 |
| C072936 | notoginsenoside R1 | notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of GSK3B protein modified form] | 23170834 |
| C072936 | notoginsenoside R1 | wortmannin inhibits the reaction [notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of GSK3B protein modified form]] | 23170834 |
| C072936 | notoginsenoside R1 | notoginsenoside R1 results in increased expression of GSK3B protein modified form | 24720662 |
| C404397 | NSC 680410 | NSC 680410 results in decreased phosphorylation of GSK3B protein | 14647418 |
| C558013 | NSC 689534 | [NSC 689534 binds to Copper] which results in increased expression of GSK3B mRNA | 20971185 |
| C025589 | ochratoxin A | ochratoxin A results in increased phosphorylation of GSK3B protein | 25002221 |
| D019319 | Okadaic Acid | [5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein] | 21715663 |
| D019319 | Okadaic Acid | [5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein modified form] | 21715663 |
| D019319 | Okadaic Acid | "N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein]" | 21715663 |
| D019319 | Okadaic Acid | "N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein modified form]" | 21715663 |
| D019319 | Okadaic Acid | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] inhibits the reaction [Okadaic Acid results in increased phosphorylation of MAPT protein]" | 21715663 |
| D019319 | Okadaic Acid | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] which results in decreased susceptibility to Okadaic Acid" | 21715663 |
| D019319 | Okadaic Acid | Okadaic Acid inhibits the reaction [resveratrol results in decreased phosphorylation of GSK3B protein] | 23292070 |
| D019319 | Okadaic Acid | Okadaic Acid results in increased expression of GSK3B protein | 21715663 |
| D019319 | Okadaic Acid | Okadaic Acid results in increased expression of GSK3B protein modified form | 21715663 |
| D019319 | Okadaic Acid | [PNU-282987 binds to and results in increased activity of CHRNA7 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein] | 21715663 |
| D019319 | Okadaic Acid | [PNU-282987 binds to and results in increased activity of CHRNA7 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein modified form] | 21715663 |
| D019319 | Okadaic Acid | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [Okadaic Acid affects the phosphorylation of GSK3B protein]] | 27050422 |
| D019319 | Okadaic Acid | Lithium Chloride inhibits the reaction [Okadaic Acid affects the phosphorylation of GSK3B protein] | 27050422 |
| D019319 | Okadaic Acid | Okadaic Acid affects the phosphorylation of GSK3B protein | 27050422 |
| D019319 | Okadaic Acid | Quercetin inhibits the reaction [Okadaic Acid affects the phosphorylation of GSK3B protein] | 27050422 |
| C076029 | olanzapine | olanzapine results in increased phosphorylation of GSK3B protein | 19440698 |
| D009942 | Organometallic Compounds | Organometallic Compounds results in decreased activity of GSK3B protein | 17210701 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in decreased expression of GSK3B mRNA | 25729387 |
| D010100 | Oxygen | cobaltiprotoporphyrin promotes the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein] | 24658657 |
| D010100 | Oxygen | [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased phosphorylation of GSK3B protein | 24058562 |
| D010100 | Oxygen | Oxygen deficiency results in increased phosphorylation of GSK3B protein | 24658657 |
| D010100 | Oxygen | sodium bisulfide inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased phosphorylation of GSK3B protein] | 24058562 |
| D010100 | Oxygen | tin protoporphyrin IX inhibits the reaction [cobaltiprotoporphyrin promotes the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein]] | 24658657 |
| D000073878 | Palm Oil | Palm Oil results in decreased expression of GSK3B mRNA | 18042831 |
| D010269 | Paraquat | 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat inhibits the reaction [TNFRSF10B protein binds to GSK3B protein]] | 28414160 |
| D010269 | Paraquat | 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in decreased expression of GSK3B protein modified form] | 28414160 |
| D010269 | Paraquat | Paraquat inhibits the reaction [TNFRSF10B protein binds to GSK3B protein] | 28414160 |
| D010269 | Paraquat | Paraquat results in decreased expression of GSK3B protein | 28414160 |
| D010269 | Paraquat | Paraquat results in increased expression of and results in increased phosphorylation of GSK3B protein | 22292029 |
| D010269 | Paraquat | Paraquat results in increased phosphorylation of GSK3B protein | 24634145 |
| D052638 | Particulate Matter | Particulate Matter results in decreased expression of GSK3B mRNA | 28412507 |
| C522391 | perfluorododecanoic acid | GSK3B protein affects the susceptibility to perfluorododecanoic acid | 23353032 |
| C522391 | perfluorododecanoic acid | perfluorododecanoic acid results in decreased expression of GSK3B protein | 23353032 |
| C522391 | perfluorododecanoic acid | perfluorododecanoic acid results in decreased expression of GSK3B protein modified form | 23353032 |
| C101816 | perfluoro-n-nonanoic acid | perfluoro-n-nonanoic acid results in increased expression of GSK3B protein modified form | 22387981 |
| C076994 | perfluorooctane sulfonic acid | Lithium Chloride inhibits the reaction [perfluorooctane sulfonic acid results in decreased phosphorylation of GSK3B protein] | 27018151 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in decreased phosphorylation of GSK3B protein | 27018151 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased phosphorylation of GSK3B protein | 28947262 |
| C027579 | periodate-oxidized adenosine | periodate-oxidized adenosine affects the expression of GSK3B mRNA | 17097637 |
| D015232 | Dinoprostone | Dinoprostone results in increased phosphorylation of GSK3B protein | 18395713 |
| D015232 | Dinoprostone | Dinoprostone results in increased phosphorylation of GSK3B protein | 20578217 |
| C058305 | phenethyl isothiocyanate | Acetylcysteine inhibits the reaction [phenethyl isothiocyanate results in increased phosphorylation of GSK3B protein] | 25246272 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in increased phosphorylation of GSK3B protein | 25246272 |
| D010634 | Phenobarbital | Phenobarbital results in decreased expression of GSK3B mRNA | 23091169 |
| D010656 | Phenylephrine | GRK2 protein affects the reaction [Phenylephrine results in increased phosphorylation of GSK3B protein] | 28759639 |
| D010656 | Phenylephrine | Phenylephrine results in increased phosphorylation of GSK3B protein | 15795328|2875963 |
| D010656 | Phenylephrine | SGK1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of GSK3B protein] | 15795328 |
| D010693 | Phloretin | Phloretin results in decreased activity of GSK3B protein | 16968061 |
| D010696 | Phloroglucinol | Phloroglucinol analog results in decreased phosphorylation of GSK3B protein | 23178381 |
| D010743 | Phospholipids | Phospholipids results in increased phosphorylation of GSK3B protein | 15956784 |
| D064209 | Phytochemicals | Phytochemicals results in decreased phosphorylation of GSK3B protein | 22685690 |
| D048789 | Phytoestrogens | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phytoestrogens results in increased phosphorylation of GSK3B protein] | 24726523 |
| D048789 | Phytoestrogens | fulvestrant inhibits the reaction [Phytoestrogens results in increased phosphorylation of GSK3B protein] | 24726523 |
| D048789 | Phytoestrogens | Phytoestrogens results in increased phosphorylation of GSK3B protein | 24726523 |
| C544307 | PI 620 | PI 620 results in decreased phosphorylation of GSK3B protein | 19584227 |
| D010936 | Plant Extracts | Plant Extracts results in decreased phosphorylation of GSK3B protein | 22685690 |
| D010936 | Plant Extracts | Plant Extracts results in decreased activity of GSK3B protein | 24380755 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Streptozocin results in increased expression of GSK3B mRNA] | 27038876 |
| C498513 | PNU-282987 | [PNU-282987 binds to and results in increased activity of CHRNA7 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein] | 21715663 |
| C498513 | PNU-282987 | [PNU-282987 binds to and results in increased activity of CHRNA7 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein modified form] | 21715663 |
| C498513 | PNU-282987 | [PNU-282987 binds to and results in increased activity of CHRNA7 protein] which results in increased phosphorylation of GSK3B protein | 21715663 |
| D011078 | Polychlorinated Biphenyls | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Polychlorinated Biphenyls analog results in decreased expression of GSK3B protein] | 24361488 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls analog results in decreased expression of GSK3B protein | 24361488 |
| D011188 | Potassium | Potassium results in increased phosphorylation of and results in decreased activity of GSK3B protein | 15950778 |
| C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GSK3B mRNA | 22079256 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of GSK3B mRNA | 22079256 |
| D011280 | Pregnanolone | Pregnanolone results in decreased expression of GSK3B protein | 17443805 |
| D011335 | Proadifen | GSK3B protein affects the susceptibility to Proadifen | 22683934 |
| D011335 | Proadifen | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] which results in decreased susceptibility to Proadifen" | 22683934 |
| C479580 | procyanidin B2 | procyanidin B2 inhibits the reaction [MFGE8 protein results in decreased expression of GSK3B protein modified form] | 21505870 |
| C479580 | procyanidin B2 | procyanidin B2 results in increased expression of GSK3B protein modified form | 21505870 |
| D011374 | Progesterone | Mifepristone inhibits the reaction [Progesterone results in increased phosphorylation of GSK3B protein] | 16882987 |
| D011374 | Progesterone | Progesterone results in increased phosphorylation of GSK3B protein | 16882987 |
| D011374 | Progesterone | Progesterone inhibits the reaction [Estradiol results in increased phosphorylation of GSK3B protein] | 15845746 |
| D011374 | Progesterone | Estradiol inhibits the reaction [Progesterone results in decreased expression of GSK3B mRNA] | 17170212 |
| D011374 | Progesterone | Progesterone results in decreased expression of GSK3B mRNA | 17170212 |
| D011374 | Progesterone | Progesterone results in decreased expression of GSK3B protein | 17443805 |
| D011374 | Progesterone | Progesterone results in decreased phosphorylation of GSK3B protein | 17443805 |
| D011433 | Propranolol | Propranolol results in decreased phosphorylation of GSK3B protein | 22982863 |
| C107773 | pterostilbene | pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of GSK3B protein] | 20681671 |
| D011692 | Puromycin Aminonucleoside | mizoribine inhibits the reaction [Puromycin Aminonucleoside results in increased phosphorylation of GSK3B protein] | 20502051 |
| D011692 | Puromycin Aminonucleoside | Puromycin Aminonucleoside results in increased phosphorylation of GSK3B protein | 20502051 |
| C014175 | pyrazolo(3,4-d)pyrimidine | "pyrazolo(3,4-d)pyrimidine analog affects the expression of GSK3B mRNA" | 21152443 |
| C014175 | pyrazolo(3,4-d)pyrimidine | "pyrazolo(3,4-d)pyrimidine analog affects the expression of GSK3B mRNA" | 21152443 |
| C008704 | pyrithione | AKT1 protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of and results in increased activity of GSK3B protein] | 17098228 |
| C008704 | pyrithione | GSK3B protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of MAPT protein] | 17098228 |
| C008704 | pyrithione | [Zinc co-treated with pyrithione] results in increased phosphorylation of and results in increased activity of GSK3B protein | 17098228 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid results in increased phosphorylation of GSK3B protein | 17409235 |
| D011794 | Quercetin | Quercetin promotes the reaction [arctigenin results in decreased phosphorylation of GSK3B protein] | 25380086 |
| D011794 | Quercetin | Quercetin results in decreased activity of GSK3B protein | 16968061 |
| D011794 | Quercetin | Quercetin results in decreased expression of GSK3B mRNA | 23727915 |
| D011794 | Quercetin | Quercetin results in decreased expression of GSK3B protein | 16968065 |
| D011794 | Quercetin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [Okadaic Acid affects the phosphorylation of GSK3B protein]] | 27050422 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Dietary Fats results in increased expression of GSK3B mRNA] | 27260466 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Okadaic Acid affects the phosphorylation of GSK3B protein] | 27050422 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in decreased expression of GSK3B protein] | 25164625 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[Warfarin co-treated with Vitamin K] results in increased phosphorylation of GSK3B protein] | 23117658 |
| D011796 | Quinacrine | GSK3B protein affects the reaction [Quinacrine results in decreased expression of CCND1 protein] | 28720477 |
| D011796 | Quinacrine | GSK3B protein affects the reaction [Quinacrine results in decreased expression of CTNNB1 protein] | 28720477 |
| D011796 | Quinacrine | GSK3B protein affects the reaction [Quinacrine results in decreased expression of GLI1 protein] | 28720477 |
| D011796 | Quinacrine | GSK3B protein affects the reaction [Quinacrine results in decreased expression of MYC protein] | 28720477 |
| D011796 | Quinacrine | GSK3B protein affects the reaction [Quinacrine results in increased activity of CASP3 protein] | 28720477 |
| D011796 | Quinacrine | GSK3B protein affects the reaction [Quinacrine results in increased expression of CSNK1A1 protein] | 28720477 |
| D011796 | Quinacrine | Quinacrine results in increased expression of and results in decreased phosphorylation of GSK3B protein | 28720477 |
| D011796 | Quinacrine | Quinacrine results in increased expression of GSK3B mRNA | 28720477 |
| C502851 | quinocetone | Lithium Chloride promotes the reaction [quinocetone affects the phosphorylation of and results in decreased activity of GSK3B protein] | 28343033 |
| C502851 | quinocetone | quinocetone affects the phosphorylation of and results in decreased activity of GSK3B protein | 28343033 |
| C052785 | rebamipide | rebamipide results in increased expression of GSK3B mRNA | 18299717 |
| C059514 | resveratrol | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein] | 20696143 |
| C059514 | resveratrol | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein] | 20696143 |
| C059514 | resveratrol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein] | 20696143 |
| C059514 | resveratrol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of GSK3B protein] | 14750165 |
| C059514 | resveratrol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein] | 20696143 |
| C059514 | resveratrol | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in decreased activity of GSK3B protein]" | 19620254 |
| C059514 | resveratrol | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in increased phosphorylation of GSK3B protein]" | 19620254 |
| C059514 | resveratrol | ARRB2 protein affects the reaction [resveratrol results in decreased expression of GSK3B protein modified form] | 20457218 |
| C059514 | resveratrol | GSK3B protein affects the reaction [resveratrol results in increased expression of FTH1 mRNA] | 23829535 |
| C059514 | resveratrol | Okadaic Acid inhibits the reaction [resveratrol results in decreased phosphorylation of GSK3B protein] | 23292070 |
| C059514 | resveratrol | resveratrol affects the expression of GSK3B protein modified form | 22234583 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Excitatory Amino Acid Agonists affects the phosphorylation of GSK3B protein] | 24675465 |
| C059514 | resveratrol | resveratrol inhibits the reaction [GSK3B protein binds to SIRT1 protein] | 23292070 |
| C059514 | resveratrol | resveratrol inhibits the reaction [MFGE8 protein results in decreased expression of GSK3B protein modified form] | 21505870 |
| C059514 | resveratrol | resveratrol results in decreased activity of GSK3B protein | 19620254 |
| C059514 | resveratrol | resveratrol results in decreased expression of GSK3B protein modified form | 20133117|2045721 |
| C059514 | resveratrol | resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein | 20696143 |
| C059514 | resveratrol | [resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased phosphorylation of and results in decreased localization of CTNNB1 protein | 20696143 |
| C059514 | resveratrol | resveratrol results in decreased phosphorylation of GSK3B protein | 14750165|2009093 |
| C059514 | resveratrol | [resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSF1 mRNA | 20090934 |
| C059514 | resveratrol | [resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSPA1A protein | 20090934 |
| C059514 | resveratrol | resveratrol results in increased activity of GSK3B protein | 17868649|2009093 |
| C059514 | resveratrol | [resveratrol results in increased activity of GSK3B protein] which results in decreased expression of HSF1 mRNA | 20090934 |
| C059514 | resveratrol | resveratrol results in increased expression of GSK3B protein modified form | 21505870 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein | 20696143 |
| C059514 | resveratrol | [resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein] which results in decreased phosphorylation of and results in increased localization of CTNNB1 protein | 20696143 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of GSK3B protein | 14750165|1962025 |
| C059514 | resveratrol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein] | 20542495 |
| C059514 | resveratrol | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose]" | 22180358 |
| C059514 | resveratrol | resveratrol affects the phosphorylation of GSK3B protein | 24254769 |
| C059514 | resveratrol | [resveratrol co-treated with Excitatory Amino Acid Agents] results in increased phosphorylation of and results in decreased activity of GSK3B protein | 20542495 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Dietary Fats results in increased expression of GSK3B mRNA] | 24812660|2726046 |
| C059514 | resveratrol | resveratrol results in decreased activity of GSK3B protein | 19665018 |
| C059514 | resveratrol | resveratrol results in decreased expression of GSK3B protein | 19665018 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein | 20542495 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of GSK3B protein | 19665018|2218035 |
| C059514 | resveratrol | [resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose | 22180358 |
| C059514 | resveratrol | "1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [resveratrol results in increased activity of GSK3B protein]" | 19135050 |
| C059514 | resveratrol | resveratrol inhibits the reaction [APP protein modified form results in decreased expression of GSK3B protein modified form] | 25654502 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Excitatory Amino Acid Agonists affects the phosphorylation of GSK3B protein] | 24675465 |
| C059514 | resveratrol | resveratrol results in decreased phosphorylation of GSK3B protein | 24675465 |
| C059514 | resveratrol | [resveratrol results in increased activity of GSK3B protein] which results in increased phosphorylation of VASP protein | 19135050 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein | 16860989 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of GSK3B protein | 19135050 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of GSK3B protein | 22857612 |
| D018967 | Risperidone | DRD2 protein affects the reaction [Risperidone results in increased expression of GSK3B protein] | 16144542 |
| D018967 | Risperidone | Risperidone results in increased expression of GSK3B protein | 16144542 |
| C064758 | Ro 31-8220 | Ro 31-8220 results in decreased activity of GSK3B protein | 10998351 |
| C089730 | rosiglitazone | rosiglitazone results in increased phosphorylation of GSK3B protein | 25796170 |
| C089730 | rosiglitazone | rosiglitazone results in decreased activity of GSK3B protein | 19621015 |
| C089730 | rosiglitazone | rosiglitazone results in increased phosphorylation of GSK3B protein | 19566839 |
| C089730 | rosiglitazone | wortmannin inhibits the reaction [rosiglitazone results in increased phosphorylation of GSK3B protein] | 19566839 |
| C089730 | rosiglitazone | GSK3B affects the reaction [rosiglitazone inhibits the reaction [TNF protein results in increased activity of MMP9 protein]] | 19201691 |
| C089730 | rosiglitazone | GSK3B protein mutant form affects the reaction [rosiglitazone inhibits the reaction [TNF protein affects the localization of RELA protein]] | 19201691 |
| C089730 | rosiglitazone | rosiglitazone affects the reaction [PDGFB protein results in increased phosphorylation of GSK3B protein] | 19201691 |
| D012402 | Rotenone | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein]]" | 28245986 |
| D012402 | Rotenone | Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein] | 28245986 |
| D012402 | Rotenone | PARK7 protein affects the reaction [Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein]] | 28245986 |
| D012402 | Rotenone | Rotenone results in decreased phosphorylation of GSK3B protein | 28245986 |
| D012402 | Rotenone | Rotenone affects the expression of GSK3B mRNA | 23186747 |
| D012402 | Rotenone | "1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein]" | 25433145 |
| D012402 | Rotenone | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein]]" | 28245986 |
| D012402 | Rotenone | Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein] | 28245986 |
| D012402 | Rotenone | PARK7 protein affects the reaction [Bibenzyls inhibits the reaction [Rotenone results in decreased phosphorylation of GSK3B protein]] | 28245986 |
| D012402 | Rotenone | Rotenone results in decreased phosphorylation of GSK3B protein | 25433145|2824598 |
| C085746 | rottlerin | [Cadmium co-treated with rottlerin] results in decreased expression of GSK3B protein | 27658547 |
| C085746 | rottlerin | rottlerin inhibits the reaction [Cadmium results in increased phosphorylation of GSK3B protein] | 27658547 |
| C085746 | rottlerin | rottlerin results in decreased expression of GSK3B protein | 27658547 |
| C046245 | rubimaillin | rubimaillin results in increased phosphorylation of GSK3B protein | 23466342 |
| D012428 | Ruthenium | Ruthenium results in decreased activity of GSK3B protein | 17210701 |
| D017975 | Ruthenium Compounds | Ruthenium Compounds results in decreased activity of GSK3B protein | 16858717|1721070 |
| C010327 | salinomycin | salinomycin results in decreased expression of GSK3B mRNA | 19682730 |
| C036617 | salsolinol | salsolinol results in decreased phosphorylation of GSK3B protein | 23261589 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [DEFA1 protein results in increased phosphorylation of GSK3B protein] | 19814765 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [DEFA2 protein results in increased phosphorylation of GSK3B protein] | 19814765 |
| C093642 | SB 203580 | SB 203580 results in decreased activity of GSK3B protein | 10998351 |
| C417521 | SB 216763 | SB 216763 results in decreased activity of GSK3B protein | 19486905 |
| C417521 | SB 216763 | PIK3CA protein affects the reaction [SB 216763 results in increased phosphorylation of and results in decreased activity of GSK3B protein] | 19196980 |
| C417521 | SB 216763 | SB 216763 inhibits the reaction [cinobufagin results in increased expression of GSK3B protein modified form] | 23164673 |
| C417521 | SB 216763 | SB 216763 results in decreased activity of GSK3B protein | 19823589 |
| C417521 | SB 216763 | [SB 216763 results in decreased activity of GSK3B protein] inhibits the reaction [Sirolimus results in decreased expression of CCND1 protein] | 15753396 |
| C417521 | SB 216763 | [SB 216763 results in decreased activity of GSK3B protein] results in decreased susceptibility to [Arachidonic Acid co-treated with Iron] | 19620254 |
| C417521 | SB 216763 | [SB 216763 results in decreased activity of GSK3B protein] which results in increased expression of HSPA1A protein alternative form | 20090934 |
| C417521 | SB 216763 | SB 216763 results in decreased phosphorylation of and results in decreased activity of GSK3B protein | 21980429 |
| C417521 | SB 216763 | SB 216763 results in decreased phosphorylation of GSK3B protein | 16170020 |
| C417521 | SB 216763 | SB 216763 results in increased expression of and results in increased phosphorylation of and results in decreased activity of GSK3B protein | 19196980 |
| C417521 | SB 216763 | SB 216763 results in decreased activity of GSK3B protein | 19159680 |
| C417521 | SB 216763 | [SB 216763 results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein | 19159680 |
| C417521 | SB 216763 | SB 216763 results in decreased phosphorylation of GSK3B protein | 19448134 |
| C417521 | SB 216763 | SB 216763 inhibits the reaction [Excitatory Amino Acid Agonists affects the phosphorylation of GSK3B protein] | 24675465 |
| C417521 | SB 216763 | SB 216763 results in decreased activity of GSK3B protein | 16288908 |
| C417521 | SB 216763 | SB 216763 binds to and results in decreased activity of GSK3B protein | 15958644 |
| C417521 | SB 216763 | SB 216763 results in decreased activity of GSK3B protein | 15979805|1721070 |
| D012643 | Selenium | [Selenium co-treated with Vitamin E] results in increased expression of GSK3B mRNA | 19244175 |
| D012643 | Selenium | Selenium inhibits the reaction [Doxorubicin results in increased phosphorylation of GSK3B protein] | 17339365 |
| D012643 | Selenium | Selenium results in decreased expression of GSK3B mRNA | 19244175 |
| D012643 | Selenium | Selenium results in decreased phosphorylation of GSK3B protein | 17339365 |
| D017632 | Asbestos, Serpentine | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one analog inhibits the reaction [Asbestos, Serpentine results in increased phosphorylation of GSK3B protein]" | 26685284 |
| D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased phosphorylation of GSK3B protein" | 26685284 |
| D012715 | Sesame Oil | Sesame Oil results in increased expression of GSK3B mRNA | 29191790 |
| C042431 | S-ethyl glutathione | S-ethyl glutathione inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| C042431 | S-ethyl glutathione | S-ethyl glutathione results in increased phosphorylation of GSK3B protein | 25246272 |
| C009250 | sevoflurane | Lithium Chloride inhibits the reaction [sevoflurane results in decreased phosphorylation of GSK3B protein] | 20807582 |
| C009250 | sevoflurane | sevoflurane results in decreased phosphorylation of GSK3B protein | 20807582 |
| C040115 | shogaol | shogaol results in increased expression of and results in increased phosphorylation of GSK3B protein | 27645308 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased phosphorylation of GSK3B protein | 24831964 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased phosphorylation of GSK3B protein | 24831964 |
| D012834 | Silver | Silver results in increased expression of GSK3B mRNA | 29283201 |
| D012834 | Silver | Silver affects the phosphorylation of GSK3B protein | 27593553 |
| D019821 | Simvastatin | Simvastatin results in increased expression of GSK3B | 19461118 |
| D019821 | Simvastatin | Simvastatin inhibits the reaction [Glucose results in decreased phosphorylation of and results in increased activity of GSK3B protein] | 18004065 |
| D019821 | Simvastatin | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of GSK3B protein] | 18047562 |
| D019821 | Simvastatin | Simvastatin results in increased expression of GSK3B protein modified form | 18004065 |
| D020123 | Sirolimus | [Sirolimus results in decreased activity of MTOR protein] which results in increased phosphorylation of GSK3B protein | 17908691 |
| D020123 | Sirolimus | "[3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione results in decreased activity of GSK3B protein] inhibits the reaction [Sirolimus results in decreased expression of CCND1 protein]" | 15753396 |
| D020123 | Sirolimus | [Lithium Chloride results in decreased activity of GSK3B protein] inhibits the reaction [Sirolimus results in decreased expression of CCND1 protein] | 15753396 |
| D020123 | Sirolimus | [SB 216763 results in decreased activity of GSK3B protein] inhibits the reaction [Sirolimus results in decreased expression of CCND1 protein] | 15753396 |
| D020123 | Sirolimus | [Sirolimus results in decreased activity of MTOR protein] which results in increased phosphorylation of GSK3B protein | 17908691 |
| D020123 | Sirolimus | Sirolimus results in increased activity of GSK3B protein | 15753396 |
| D020123 | Sirolimus | [Sirolimus results in increased activity of GSK3B protein] which results in increased phosphorylation of and results in increased degradation of CCND1 protein | 15753396 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TSC1 gene mutant form results in decreased phosphorylation of GSK3B protein] | 18495876 |
| C009277 | sodium arsenate | sodium arsenate results in decreased expression of GSK3B mRNA | 21795629 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of GSK3B mRNA | 21795629 |
| C017947 | sodium arsenite | sodium arsenite affects the expression of GSK3B mRNA | 22058191 |
| C017947 | sodium arsenite | [Ethanol co-treated with sodium arsenite] results in increased phosphorylation of GSK3B protein | 26220687 |
| C017947 | sodium arsenite | Lithium promotes the reaction [sodium arsenite results in increased phosphorylation of GSK3B protein] | 17849503 |
| C017947 | sodium arsenite | [sodium arsenite co-treated with Ethanol] results in increased phosphorylation of GSK3B protein | 22872060 |
| C017947 | sodium arsenite | sodium arsenite results in decreased phosphorylation of GSK3B protein | 20043101 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of GSK3B protein modified form | 16054901 |
| C017947 | sodium arsenite | sodium arsenite results in increased phosphorylation of and results in increased activity of GSK3B protein | 12614848 |
| C017947 | sodium arsenite | sodium arsenite results in increased phosphorylation of GSK3B protein | 17849503|2285922 |
| C017947 | sodium arsenite | wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of GSK3B protein] | 12614848 |
| C017947 | sodium arsenite | sodium arsenite results in increased phosphorylation of GSK3B protein | 12529330 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of GSK3B mRNA | 22155349 |
| C025451 | sodium bisulfide | sodium bisulfide inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased phosphorylation of GSK3B protein] | 24058562 |
| D012969 | Sodium Fluoride | DKK1 protein inhibits the reaction [Sodium Fluoride results in increased phosphorylation of GSK3B protein] | 24300170 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in increased phosphorylation of GSK3B protein | 24300170 |
| D018038 | Sodium Selenite | Sodium Selenite results in decreased expression of GSK3B mRNA | 18175754 |
| C471405 | sorafenib | arsenic trioxide inhibits the reaction [sorafenib results in increased phosphorylation of GSK3B protein] | 25416439 |
| C471405 | sorafenib | GSK3B inhibits the reaction [sorafenib affects the localization of AIFM1 protein] | 17991738 |
| C471405 | sorafenib | GSK3B inhibits the reaction [sorafenib affects the localization of DIABLO protein] | 17991738 |
| C471405 | sorafenib | sorafenib inhibits the reaction [arsenic trioxide results in decreased phosphorylation of GSK3B protein] | 25416439 |
| C471405 | sorafenib | sorafenib promotes the reaction [GSK3B protein results in increased phosphorylation of MYC protein] | 17991738 |
| C471405 | sorafenib | sorafenib promotes the reaction [GSK3B protein results in increased phosphorylation of TP53 protein] | 17991738 |
| C471405 | sorafenib | sorafenib results in decreased phosphorylation of and results in increased activity of GSK3B protein | 17991738 |
| C471405 | sorafenib | sorafenib results in increased phosphorylation of GSK3B protein | 25416439 |
| D013311 | Streptozocin | Curcumin inhibits the reaction [Streptozocin results in decreased phosphorylation of GSK3B protein] | 25541178 |
| D013311 | Streptozocin | Plant Extracts inhibits the reaction [Streptozocin results in increased expression of GSK3B mRNA] | 27038876 |
| D013311 | Streptozocin | Streptozocin results in decreased phosphorylation of GSK3B protein | 25541178 |
| D013311 | Streptozocin | Streptozocin results in increased expression of GSK3B mRNA | 27038876 |
| D004113 | Succimer | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GSK3B mRNA | 21641980 |
| D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] affects the expression of GSK3B mRNA | 26378955 |
| D013467 | Sulindac | Sulindac results in decreased phosphorylation of GSK3B protein | 11593435 |
| D013605 | T-2 Toxin | T-2 Toxin results in decreased expression of GSK3B mRNA | 26141394 |
| D016559 | Tacrolimus | [GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein] | 22416070 |
| D016559 | Tacrolimus | Tacrolimus results in increased phosphorylation of GSK3B protein | 22416070 |
| C061133 | tamibarotene | tamibarotene affects the expression of GSK3B mRNA | 15498508 |
| D013629 | Tamoxifen | Tamoxifen promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein] | 22046442 |
| D013629 | Tamoxifen | Tamoxifen results in decreased phosphorylation of and results in increased expression of GSK3B protein | 23921149 |
| C112765 | tanespimycin | tanespimycin results in decreased expression of GSK3B protein modified form | 20090934 |
| C021751 | tanshinone | tanshinone results in decreased expression of GSK3B mRNA | 25186638 |
| D013655 | Taurochenodeoxycholic Acid | Taurochenodeoxycholic Acid results in increased phosphorylation of and results in decreased activity of GSK3B protein | 20512997 |
| D013739 | Testosterone | Testosterone results in increased expression of GSK3B mRNA | 21880219 |
| D013739 | Testosterone | Testosterone results in increased expression of GSK3B mRNA | 20843997 |
| D013739 | Testosterone | [Methylnitrosourea co-treated with Testosterone] results in decreased expression of GSK3B protein | 25164625 |
| D013739 | Testosterone | Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in decreased expression of GSK3B protein] | 25164625 |
| C004648 | testosterone enanthate | testosterone enanthate affects the expression of GSK3B mRNA | 17440010 |
| C020806 | tetrabromobisphenol A | tetrabromobisphenol A results in decreased expression of GSK3B mRNA | 27914987 |
| D013749 | Tetrachlorodibenzodioxin | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of GSK3B mRNA] | 11007951 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of GSK3B mRNA | 11007951 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased phosphorylation of GSK3B protein | 27312872 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of GSK3B mRNA] | 15034205 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of GSK3B mRNA | 15034205 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased phosphorylation of GSK3B protein | 18996433 |
| D013749 | Tetrachlorodibenzodioxin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of GSK3B protein] | 24231000 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased phosphorylation of GSK3B protein | 23639626 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased phosphorylation of GSK3B protein | 24231000 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased phosphorylation of GSK3B protein | 17993264 |
| D013755 | Tetradecanoylphorbol Acetate | U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of GSK3B protein] | 17993264 |
| C050950 | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Ethanol results in increased phosphorylation of GSK3B protein] | 28962519 |
| C009438 | tetrandrine | tetrandrine results in decreased expression of GSK3B protein modified form | 25266202 |
| D013792 | Thalidomide | Thalidomide results in increased expression of GSK3B mRNA | 19751816 |
| D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [Dietary Fats results in increased expression of GSK3B mRNA] | 27260466 |
| D008063 | Thioctic Acid | Thioctic Acid results in increased phosphorylation of GSK3B protein | 19879292 |
| D013882 | Thiosemicarbazones | [Copper binds to Thiosemicarbazones analog] which results in decreased activity of GSK3B protein | 19122148 |
| D013882 | Thiosemicarbazones | [Thiosemicarbazones binds to Copper] which results in increased expression of GSK3B protein | 20931265 |
| D013893 | Thiram | Thiram results in decreased expression of GSK3B mRNA | 20530235 |
| C032628 | tin protoporphyrin IX | tin protoporphyrin IX inhibits the reaction [cobaltiprotoporphyrin promotes the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein]] | 24658657 |
| D014028 | Tobacco Smoke Pollution | GSK3B protein inhibits the reaction [Tobacco Smoke Pollution results in increased activity of [CTNNB1 protein binds to TCF4 protein]] | 19429245 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of GSK3B protein | 19429245 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased phosphorylation of and results in decreased activity of GSK3B protein | 19429245 |
| D014051 | Toluene 2,4-Diisocyanate | "2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Toluene 2,4-Diisocyanate results in increased phosphorylation of GSK3B protein]" | 26089345 |
| D014051 | Toluene 2,4-Diisocyanate | "Toluene 2,4-Diisocyanate results in increased phosphorylation of GSK3B protein" | 26089345 |
| D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in decreased expression of GSK3B mRNA | 25729387 |
| D014118 | Toxins, Biological | "Toxins, Biological affects the expression of GSK3B mRNA" | 19682533 |
| D014212 | Tretinoin | Tretinoin results in increased expression of GSK3B mRNA | 20530235 |
| D014212 | Tretinoin | nickel chloride promotes the reaction [Tretinoin results in increased phosphorylation of GSK3B protein] | 25614230 |
| D014212 | Tretinoin | Tretinoin affects the expression of GSK3B mRNA | 15498508 |
| D014212 | Tretinoin | Tretinoin results in increased phosphorylation of GSK3B protein | 25614230 |
| D014212 | Tretinoin | Tretinoin results in decreased phosphorylation of GSK3B protein | 16288212 |
| D014212 | Tretinoin | Tretinoin results in increased phosphorylation of GSK3B protein | 16288212 |
| C057693 | troglitazone | GSK3B protein affects the susceptibility to troglitazone | 20540935 |
| C057693 | troglitazone | GSK3B protein affects the susceptibility to [troglitazone results in decreased expression of CCNB1 protein] | 20540935 |
| C057693 | troglitazone | GSK3B protein affects the susceptibility to [troglitazone results in decreased expression of CCND1 protein] | 20540935 |
| C057693 | troglitazone | GSK3B protein affects the susceptibility to [troglitazone results in decreased expression of CCNE1 protein] | 20540935 |
| C057693 | troglitazone | GSK3B protein affects the susceptibility to [troglitazone results in decreased expression of CDK2 protein] | 20540935 |
| C057693 | troglitazone | GSK3B protein affects the susceptibility to [troglitazone results in decreased expression of CDK4 protein] | 20540935 |
| C057693 | troglitazone | GSK3B protein affects the susceptibility to [troglitazone results in increased expression of BAX protein] | 20540935 |
| C057693 | troglitazone | GSK3B protein affects the susceptibility to [troglitazone results in increased expression of CASP3 protein] | 20540935 |
| C057693 | troglitazone | GSK3B protein affects the susceptibility to [troglitazone results in increased expression of CASP9 protein] | 20540935 |
| C057693 | troglitazone | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CCNB1 protein]" | 20540935 |
| C057693 | troglitazone | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CCND1 protein]" | 20540935 |
| C057693 | troglitazone | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CCNE1 protein]" | 20540935 |
| C057693 | troglitazone | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CDK2 protein]" | 20540935 |
| C057693 | troglitazone | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CDK4 protein]" | 20540935 |
| C057693 | troglitazone | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of BAX protein]" | 20540935 |
| C057693 | troglitazone | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of CASP3 protein]" | 20540935 |
| C057693 | troglitazone | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of CASP9 protein]" | 20540935 |
| C057693 | troglitazone | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] which results in increased susceptibility to troglitazone" | 20540935 |
| C057693 | troglitazone | troglitazone results in decreased activity of GSK3B protein | 20540935 |
| C113580 | U 0126 | U 0126 inhibits the reaction [arsenic trioxide results in increased phosphorylation of GSK3B protein] | 21278055 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] | 25246272 |
| C113580 | U 0126 | U 0126 inhibits the reaction [EDN1 protein results in increased phosphorylation of GSK3B protein] | 17993264 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of GSK3B protein] | 17993264 |
| D014520 | Urethane | Urethane results in increased expression of GSK3B mRNA | 28818685 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSK3B mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of GSK3B mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased activity of GSK3B protein | 19101580 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of GSK3B mRNA | 26272509 |
| D014635 | Valproic Acid | Valproic Acid results in increased phosphorylation of and results in decreased activity of GSK3B protein | 19328817 |
| D014635 | Valproic Acid | Valproic Acid results in increased phosphorylation of GSK3B protein | 19440698 |
| D014635 | Valproic Acid | "4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione promotes the reaction [Valproic Acid inhibits the reaction [Kainic Acid results in decreased phosphorylation of GSK3B protein]]" | 25453207 |
| D014635 | Valproic Acid | Valproic Acid inhibits the reaction [Kainic Acid results in decreased phosphorylation of GSK3B protein] | 25453207 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of GSK3B mRNA | 19359144 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of GSK3B gene | 25560391 |
| C025643 | vinclozolin | vinclozolin affects the expression of GSK3B mRNA | 19015723 |
| D014752 | Vinyl Chloride | Vinyl Chloride metabolite results in increased expression of GSK3B mRNA | 26962056 |
| D012256 | Riboflavin | Riboflavin analog results in increased phosphorylation of GSK3B protein | 20688149 |
| D012256 | Riboflavin | Riboflavin results in increased phosphorylation of GSK3B protein | 20688149 |
| D014810 | Vitamin E | [Selenium co-treated with Vitamin E] results in increased expression of GSK3B mRNA | 19244175 |
| D014810 | Vitamin E | Vitamin E results in decreased expression of GSK3B mRNA | 19244175 |
| D014810 | Vitamin E | Vitamin E inhibits the reaction [wortmannin results in decreased expression of GSK3B protein modified form] | 15842767 |
| D014812 | Vitamin K | Quercetin inhibits the reaction [[Warfarin co-treated with Vitamin K] results in increased phosphorylation of GSK3B protein] | 23117658 |
| D014812 | Vitamin K | [Warfarin co-treated with Vitamin K] results in increased phosphorylation of GSK3B protein | 23117658 |
| D014859 | Warfarin | Quercetin inhibits the reaction [[Warfarin co-treated with Vitamin K] results in increased phosphorylation of GSK3B protein] | 23117658 |
| D014859 | Warfarin | [Warfarin co-treated with Vitamin K] results in increased phosphorylation of GSK3B protein | 23117658 |
| C085514 | wogonin | wogonin results in decreased expression of GSK3B protein modified form | 23872260 |
| C085514 | wogonin | wogonin results in decreased expression of GSK3B protein modified form | 23872260 |
| C085514 | wogonin | wogonin results in increased expression of GSK3B protein | 23872260 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Estradiol results in increased phosphorylation of GSK3B protein] | 16076840 |
| C009687 | wortmannin | wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of GSK3B protein] | 12614848 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of GSK3B protein] | 17513037 |
| C009687 | wortmannin | wortmannin results in decreased phosphorylation of GSK3B protein | 20090934|2317838 |
| C009687 | wortmannin | Melatonin inhibits the reaction [wortmannin results in decreased expression of GSK3B protein modified form] | 15842767 |
| C009687 | wortmannin | Vitamin E inhibits the reaction [wortmannin results in decreased expression of GSK3B protein modified form] | 15842767 |
| C009687 | wortmannin | wortmannin inhibits the reaction [notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of GSK3B protein modified form]] | 23170834 |
| C009687 | wortmannin | wortmannin results in decreased expression of GSK3B protein modified form | 15842767 |
| C009687 | wortmannin | wortmannin inhibits the reaction [chaetoglobosins results in increased phosphorylation of GSK3B protein] | 18040759 |
| C009687 | wortmannin | wortmannin inhibits the reaction [GRK2 protein results in increased phosphorylation of GSK3B protein] | 28759639 |
| C009687 | wortmannin | wortmannin inhibits the reaction [rosiglitazone results in increased phosphorylation of GSK3B protein] | 19566839 |
| D015032 | Zinc | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Zinc results in increased phosphorylation of GSK3B protein] | 17513037 |
| D015032 | Zinc | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of GSK3B protein] | 17513037 |
| D015032 | Zinc | Zinc results in increased phosphorylation of GSK3B protein | 17513037 |
| D015032 | Zinc | AKT1 protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of and results in increased activity of GSK3B protein] | 17098228 |
| D015032 | Zinc | GSK3B protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of MAPT protein] | 17098228 |
| D015032 | Zinc | [Zinc co-treated with pyrithione] results in increased phosphorylation of and results in increased activity of GSK3B protein | 17098228 |
| D015032 | Zinc | Zinc deficiency results in decreased phosphorylation of GSK3B protein | 21893222 |
| GO ID | GO Term | Qualifier | Evidence | PubMed |
|---|---|---|---|---|
| GO:0001085 | RNA polymerase II transcription factor binding | - | IPI | 20864106 |
| GO:0002020 | protease binding | - | IPI | 25118933 |
| GO:0002039 | p53 binding | - | IDA | 14744935 |
| GO:0004672 | protein kinase activity | - | TAS | 22988876 24115276 26049140 |
| GO:0004674 | protein serine/threonine kinase activity | - | IDA | 8638126 9072970 11035810 11104755 11955436 14744935 16315267 17139249 18348280 |
| GO:0004674 | protein serine/threonine kinase activity | - | ISS | - |
| GO:0004674 | protein serine/threonine kinase activity | - | NAS | 8725894 28386764 |
| GO:0004674 | protein serine/threonine kinase activity | - | TAS | - |
| GO:0005515 | protein binding | - | IPI | 8638126 9482734 9601641 9731200 10481074 11004522 11035810 11738041 12421363 12434148 12927815 14744935 15147888 15448698 15752768 16198352 16282323 16365045 16890161 17078951 17139249 17317006 17318191 17353931 17510365 17601533 18045539 18505846 19131971 19202075 19249679 19303846 19411070 19706605 19759537 20007971 20080667 20368287 20389281 20856200 21118991 21217772 21242974 21743491 21900206 21985244 21988832 22470507 22682247 22699938 22773187 23010592 23455922 23602568 24165324 24391509 24976009 25241761 25897075 25920809 26496610 27484798 29568061 |
| GO:0005524 | ATP binding | - | IEA | - |
| GO:0008013 | beta-catenin binding | - | IPI | 8638126 |
| GO:0016301 | kinase activity | - | IDA | 15448698 24391509 |
| GO:0016301 | kinase activity | - | TAS | - |
| GO:0019901 | protein kinase binding | - | IPI | 18348280 |
| GO:0031625 | ubiquitin protein ligase binding | - | IPI | 21118991 |
| GO:0034236 | protein kinase A catalytic subunit binding | - | IPI | 11035810 |
| GO:0034452 | dynactin binding | - | IPI | 17139249 |
| GO:0050321 | tau-protein kinase activity | - | IDA | 14690523 16365045 |
| GO:0051059 | NF-kappaB binding | - | IPI | 15465828 |
| GO ID | GO Term | Qualifier | Evidence | PubMed |
|---|---|---|---|---|
| GO:0001837 | epithelial to mesenchymal transition | - | IMP | 15448698 |
| GO:0001954 | positive regulation of cell-matrix adhesion | - | IMP | 18156211 |
| GO:0005977 | glycogen metabolic process | - | IDA | 8638126 |
| GO:0006468 | protein phosphorylation | - | IDA | 11035810 16315267 20937854 |
| GO:0006468 | protein phosphorylation | - | TAS | 26049140 |
| GO:0006983 | ER overload response | - | IDA | 14744935 |
| GO:0007212 | dopamine receptor signaling pathway | - | NAS | 21711983 |
| GO:0007623 | circadian rhythm | - | ISS | - |
| GO:0010628 | positive regulation of gene expression | - | ISS | - |
| GO:0010822 | positive regulation of mitochondrion organization | - | IMP | 25118933 |
| GO:0016055 | Wnt signaling pathway | - | TAS | - |
| GO:0018105 | peptidyl-serine phosphorylation | - | IDA | 8638126 11104755 11955436 14744935 17139249 |
| GO:0018107 | peptidyl-threonine phosphorylation | - | IDA | 11955436 17139249 25897075 |
| GO:0021766 | hippocampus development | - | IMP | 19581563 |
| GO:0030010 | establishment of cell polarity | - | ISS | - |
| GO:0030010 | establishment of cell polarity | - | TAS | 18268107 |
| GO:0030011 | maintenance of cell polarity | - | ISS | - |
| GO:0030011 | maintenance of cell polarity | - | TAS | 18268107 |
| GO:0030516 | regulation of axon extension | - | ISS | - |
| GO:0031175 | neuron projection development | - | IDA | 19830702 |
| GO:0031333 | negative regulation of protein complex assembly | - | IMP | 16188939 |
| GO:0031334 | positive regulation of protein complex assembly | - | IDA | 8638126 |
| GO:0032091 | negative regulation of protein binding | - | IDA | 16890161 |
| GO:0032092 | positive regulation of protein binding | - | ISS | - |
| GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | - | IC | 11955436 |
| GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | - | IMP | 25897075 |
| GO:0032515 | negative regulation of phosphoprotein phosphatase activity | - | TAS | 28386764 |
| GO:0032886 | regulation of microtubule-based process | - | IMP | 20937854 |
| GO:0035556 | intracellular signal transduction | - | IDA | 14749367 |
| GO:0035556 | intracellular signal transduction | - | TAS | 26049140 |
| GO:0036016 | cellular response to interleukin-3 | - | ISS | - |
| GO:0043066 | negative regulation of apoptotic process | - | IDA | 14744935 |
| GO:0043547 | positive regulation of GTPase activity | - | IMP | 18156211 |
| GO:0045719 | negative regulation of glycogen biosynthetic process | - | TAS | 19366350 |
| GO:0045732 | positive regulation of protein catabolic process | - | IC | 16188939 |
| GO:0046777 | protein autophosphorylation | - | IDA | 23184662 |
| GO:0046827 | positive regulation of protein export from nucleus | - | IDA | 14744935 |
| GO:0048814 | regulation of dendrite morphogenesis | - | ISS | - |
| GO:0050770 | regulation of axonogenesis | - | ISS | - |
| GO:0060070 | canonical Wnt signaling pathway | - | IC | 9601641 |
| GO:0060070 | canonical Wnt signaling pathway | - | IDA | 18787224 |
| GO:0060070 | canonical Wnt signaling pathway | - | TAS | 26049140 |
| GO:0060079 | excitatory postsynaptic potential | - | NAS | 21711983 |
| GO:0070507 | regulation of microtubule cytoskeleton organization | - | IMP | 17139249 |
| GO:0070507 | regulation of microtubule cytoskeleton organization | - | ISS | - |
| GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade | - | IMP | 9072970 |
| GO:0071109 | superior temporal gyrus development | - | IMP | 19581563 |
| GO:0090090 | negative regulation of canonical Wnt signaling pathway | - | IC | 11955436 |
| GO:0090090 | negative regulation of canonical Wnt signaling pathway | - | TAS | 19366350 |
| GO:0097191 | extrinsic apoptotic signaling pathway | - | ISS | - |
| GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | - | ISS | - |
| GO:0106028 | neuron projection retraction | - | ISS | - |
| GO:1900034 | regulation of cellular response to heat | - | TAS | - |
| GO:1900181 | negative regulation of protein localization to nucleus | - | ISS | - |
| GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | - | ISS | - |
| GO:1901215 | negative regulation of neuron death | - | IDA | 19830702 |
| GO:1901216 | positive regulation of neuron death | - | IDA | 18508033 |
| GO:1901984 | negative regulation of protein acetylation | - | ISS | - |
| GO:1904339 | negative regulation of dopaminergic neuron differentiation | - | TAS | 24431302 |
| GO:1904646 | cellular response to amyloid-beta | - | ISS | - |
| GO:1904781 | positive regulation of protein localization to centrosome | - | IMP | 17139249 |
| GO:1904885 | beta-catenin destruction complex assembly | - | TAS | - |
| GO:1904886 | beta-catenin destruction complex disassembly | - | TAS | - |
| GO:2000077 | negative regulation of type B pancreatic cell development | - | TAS | 19366350 |
| GO:2000466 | negative regulation of glycogen (starch) synthase activity | - | TAS | 19366350 |
| GO ID | GO Term | Qualifier | Evidence | PubMed |
|---|---|---|---|---|
| GO:0005634 | nucleus | - | IDA | 14744935 15448698 |
| GO:0005654 | nucleoplasm | - | TAS | - |
| GO:0005737 | cytoplasm | - | IDA | 14744935 15448698 18787224 19038973 20937854 |
| GO:0005739 | mitochondrion | - | IEA | - |
| GO:0005813 | centrosome | - | IDA | 17139249 21399614 |
| GO:0005829 | cytosol | - | TAS | - |
| GO:0005886 | plasma membrane | - | IDA | 20937854 |
| GO:0030424 | axon | - | ISS | - |
| GO:0030425 | dendrite | - | ISS | - |
| GO:0030877 | beta-catenin destruction complex | - | IDA | 8638126 9601641 16188939 |
| GO:0030877 | beta-catenin destruction complex | - | TAS | 11955436 19366350 |
| GO:0098794 | postsynapse | - | IEA | - |
| GO:1990909 | Wnt signalosome | - | TAS | 24115276 |
| KEGG ID | KEGG Term |
|---|---|
| hsa04012 | ErbB signaling pathway |
| hsa04062 | Chemokine signaling pathway |
| hsa04110 | Cell cycle |
| hsa04310 | Wnt signaling pathway |
| hsa04340 | Hedgehog signaling pathway |
| hsa04360 | Axon guidance |
| hsa04510 | Focal adhesion |
| hsa04660 | T cell receptor signaling pathway |
| hsa04662 | B cell receptor signaling pathway |
| hsa04722 | Neurotrophin signaling pathway |
| hsa04910 | Insulin signaling pathway |
| hsa04916 | Melanogenesis |
| hsa05010 | Alzheimer's disease |
| hsa05160 | Hepatitis C |
| hsa05200 | Pathways in cancer |
| hsa05210 | Colorectal cancer |
| hsa05213 | Endometrial cancer |
| hsa05215 | Prostate cancer |
| hsa05217 | Basal cell carcinoma |
| Reactome ID | Reactome Term | Evidence |
|---|---|---|
| R-HSA-1257604 | PIP3 activates AKT signaling | IEA |
| R-HSA-1266738 | Developmental Biology | TAS |
| R-HSA-162582 | Signal Transduction | TAS |
| R-HSA-162582 | Signal Transduction | IEA |
| R-HSA-1640170 | Cell Cycle | IEA |
| R-HSA-1643685 | Disease | TAS |
| R-HSA-195253 | Degradation of beta-catenin by the destruction complex | TAS |
| R-HSA-195721 | Signaling by WNT | TAS |
| R-HSA-195721 | Signaling by WNT | IEA |
| R-HSA-196299 | Beta-catenin phosphorylation cascade | TAS |
| R-HSA-198323 | AKT phosphorylates targets in the cytosol | IEA |
| R-HSA-201681 | TCF dependent signaling in response to WNT | TAS |
| R-HSA-201681 | TCF dependent signaling in response to WNT | IEA |
| R-HSA-212165 | Epigenetic regulation of gene expression | TAS |
| R-HSA-212436 | Generic Transcription Pathway | IEA |
| R-HSA-2219528 | PI3K/AKT Signaling in Cancer | TAS |
| R-HSA-2262752 | Cellular responses to stress | TAS |
| R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | TAS |
| R-HSA-3371556 | Cellular response to heat stress | TAS |
| R-HSA-373755 | Semaphorin interactions | TAS |
| R-HSA-399956 | CRMPs in Sema3A signaling | TAS |
| R-HSA-422475 | Axon guidance | TAS |
| R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | TAS |
| R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | IEA |
| R-HSA-4791275 | Signaling by WNT in cancer | TAS |
| R-HSA-4839735 | AXIN mutants destabilize the destruction complex, activating WNT signaling | TAS |
| R-HSA-4839743 | phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | TAS |
| R-HSA-4839744 | truncated APC mutants destabilize the destruction complex | TAS |
| R-HSA-4839748 | AMER1 mutants destabilize the destruction complex | TAS |
| R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | TAS |
| R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | TAS |
| R-HSA-5339716 | Misspliced GSK3beta mutants stabilize beta-catenin | TAS |
| R-HSA-5358351 | Signaling by Hedgehog | TAS |
| R-HSA-5358351 | Signaling by Hedgehog | IEA |
| R-HSA-5358747 | S33 mutants of beta-catenin aren't phosphorylated | TAS |
| R-HSA-5358749 | S37 mutants of beta-catenin aren't phosphorylated | TAS |
| R-HSA-5358751 | S45 mutants of beta-catenin aren't phosphorylated | TAS |
| R-HSA-5358752 | T41 mutants of beta-catenin aren't phosphorylated | TAS |
| R-HSA-5467337 | APC truncation mutants have impaired AXIN binding | TAS |
| R-HSA-5467340 | AXIN missense mutants destabilize the destruction complex | TAS |
| R-HSA-5467348 | Truncations of AMER1 destabilize the destruction complex | TAS |
| R-HSA-5610783 | Degradation of GLI2 by the proteasome | IEA |
| R-HSA-5610785 | GLI3 is processed to GLI3R by the proteasome | TAS |
| R-HSA-5610787 | Hedgehog 'off' state | TAS |
| R-HSA-5610787 | Hedgehog 'off' state | IEA |
| R-HSA-5663202 | Diseases of signal transduction | TAS |
| R-HSA-5674400 | Constitutive Signaling by AKT1 E17K in Cancer | TAS |
| R-HSA-69229 | Ubiquitin-dependent degradation of Cyclin D1 | IEA |
| R-HSA-69242 | S Phase | IEA |
| R-HSA-69278 | Cell Cycle, Mitotic | IEA |
| R-HSA-73857 | RNA Polymerase II Transcription | IEA |
| R-HSA-74160 | Gene expression (Transcription) | IEA |
| R-HSA-74160 | Gene expression (Transcription) | TAS |
| R-HSA-75815 | Ubiquitin-dependent degradation of Cyclin D | IEA |
| R-HSA-8878166 | Transcriptional regulation by RUNX2 | IEA |
| R-HSA-8939902 | Regulation of RUNX2 expression and activity | IEA |
| R-HSA-8953897 | Cellular responses to external stimuli | TAS |
| R-HSA-9006925 | Intracellular signaling by second messengers | IEA |
| PMID | Title (Year) | Author | Journal |
|---|---|---|---|
| 28592245 | In silico identification of potential key regulatory factors in smoking-induced lung cancer. (2017 Jun 7) | El-Aarag SA | BMC Med Genomics |
| 17727719 | Effect of active smoking on the human bronchial epithelium transcriptome. (2007 Aug 29) | Chari R | BMC Genomics |
| 28296937 | Effects of circadian clock genes and health-related behavior on metabolic syndrome in a Taiwanese population: Evidence from association and interaction analysis. (2017) | Lin E | PLoS One |
| 22413565 | [The relationship between glycogen synthase kinase-3 beta (GSK3B) -50T/C -1727A/T polymorphisms and alcoholism]. (2011 Dec) | Yoshihara E | Nihon Arukoru Yakubutsu Igakkai Zasshi |
| 25484085 | Autophagy and ethanol neurotoxicity. (2014) | Luo J | Autophagy |